
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">



<head prefix="og: http://ogp.me/ns#">
  <title>Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells</title>




<link rel="stylesheet" href="/resource/css/screen.css?e8097f76cb8c3b543f00c9cde49751d6"/>
  <!-- allows for  extra head tags -->


<!-- hello -->
<link rel="stylesheet" type="text/css"
      href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,600">

<link media="print" rel="stylesheet" type="text/css"  href="/resource/css/print.css"/>
    <script type="text/javascript">
        var siteUrlPrefix = "/plosone/";
    </script>
  <script src="/resource/js/vendor/modernizr-v2.7.1.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/detectizr.min.js" type="text/javascript"></script>

  <link rel="shortcut icon" href="/resource/img/favicon.ico" type="image/x-icon"/>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>






  <link rel="canonical" href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0096343" />
  <meta name="description" content="Neuroblastoma is one of the most common solid tumors and accounts for &sim;15% of all the cancer related deaths in the children. Despite the standard therapy for advanced disease including chemotherapy, surgery, and radiation, the mortality rate remains high for these patients. Hence, novel therapeutic agents are desperately needed. Here we examined the anticancer activity of a novel plant-derived compound, sparstolonin B (SsnB; 8,5&prime;-dihydroxy-4-phenyl-5,2&prime;-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was recently isolated from an aquatic Chinese herb, Sparganium stoloniferum, and tubers of this herb have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. Our cell viability and morphological analysis indicated that SsnB at 10 &micro;M concentration significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc nonamplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells. The flow cytometric analyses suggested that SsnB arrests the cell cycle progression at G2-M phase in all neuroblastoma cell lines tested. Exposure of SsnB inhibited the compact spheroid formation and reduced the tumorigenicity of SH-SY5Y cells and SK-N-BE(2) cells in in vitro 3-D cell culture assays (anchorage-independent colony formation assay and hanging drop assay). SsnB lowers the cellular level of glutathione (GSH), increases generation of reactive oxygen species and activates the cleavage of caspase-3 whereas co-incubation of a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases the neuroblastoma cell viability. Our results for the first time demonstrate that SsnB possesses anticancer activity indicating that SsnB-induced reactive oxygen species generation promotes apoptotic cell death in neuroblastoma cells of different genetic background. Thus these data suggest that SsnB can be a promising drug candidate in neuroblastoma therapy." />

  <meta name="citation_abstract" content="Neuroblastoma is one of the most common solid tumors and accounts for &sim;15% of all the cancer related deaths in the children. Despite the standard therapy for advanced disease including chemotherapy, surgery, and radiation, the mortality rate remains high for these patients. Hence, novel therapeutic agents are desperately needed. Here we examined the anticancer activity of a novel plant-derived compound, sparstolonin B (SsnB; 8,5&prime;-dihydroxy-4-phenyl-5,2&prime;-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was recently isolated from an aquatic Chinese herb, Sparganium stoloniferum, and tubers of this herb have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. Our cell viability and morphological analysis indicated that SsnB at 10 &micro;M concentration significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc nonamplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells. The flow cytometric analyses suggested that SsnB arrests the cell cycle progression at G2-M phase in all neuroblastoma cell lines tested. Exposure of SsnB inhibited the compact spheroid formation and reduced the tumorigenicity of SH-SY5Y cells and SK-N-BE(2) cells in in vitro 3-D cell culture assays (anchorage-independent colony formation assay and hanging drop assay). SsnB lowers the cellular level of glutathione (GSH), increases generation of reactive oxygen species and activates the cleavage of caspase-3 whereas co-incubation of a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases the neuroblastoma cell viability. Our results for the first time demonstrate that SsnB possesses anticancer activity indicating that SsnB-induced reactive oxygen species generation promotes apoptotic cell death in neuroblastoma cells of different genetic background. Thus these data suggest that SsnB can be a promising drug candidate in neuroblastoma therapy.">


  <meta name="keywords" content="Neuroblastoma cells,Reactive oxygen species,Apoptosis,Cell cycle and cell division,Neuroblastoma,Cancer treatment,MTT assay,Malignant tumors" />


<meta name="citation_doi" content="10.1371/journal.pone.0096343"/>
<meta name="citation_author" content="Ambrish Kumar"/>
  <meta name="citation_author_institution" content="Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America"/>
<meta name="citation_author" content="Daping Fan"/>
  <meta name="citation_author_institution" content="Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America"/>
<meta name="citation_author" content="Donald J. DiPette"/>
  <meta name="citation_author_institution" content="Department of Internal Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America"/>
<meta name="citation_author" content="Ugra S. Singh"/>
  <meta name="citation_author_institution" content="Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America"/>

<meta name="citation_title" content="Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells"/>
<meta itemprop="name" content="Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells"/>
<meta name="citation_journal_title" content="PLOS ONE"/>
<meta name="citation_journal_abbrev" content="PLOS ONE"/>
<meta name="citation_date" content="May 1, 2014"/>
<meta name="citation_firstpage" content="e96343"/>
<meta name="citation_issue" content="5"/>
<meta name="citation_volume" content="9"/>
<meta name="citation_issn" content="1932-6203"/>
<meta name="citation_publisher" content="Public Library of Science"/>

  <meta name="citation_pdf_url" content="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096343&type=printable">

  <meta name="citation_article_type" content="Research Article">

<meta name="dc.identifier" content="10.1371/journal.pone.0096343" />


  <meta name="twitter:card" content="summary" />
  <meta name="twitter:site" content="plosone"/>
    <meta name="twitter:title" content="Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells" />
    <meta property="twitter:description" content="Neuroblastoma is one of the most common solid tumors and accounts for &sim;15% of all the cancer related deaths in the children. Despite the standard therapy for advanced disease including chemotherapy, surgery, and radiation, the mortality rate remains high for these patients. Hence, novel therapeutic agents are desperately needed. Here we examined the anticancer activity of a novel plant-derived compound, sparstolonin B (SsnB; 8,5&prime;-dihydroxy-4-phenyl-5,2&prime;-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was recently isolated from an aquatic Chinese herb, Sparganium stoloniferum, and tubers of this herb have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. Our cell viability and morphological analysis indicated that SsnB at 10 &micro;M concentration significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc nonamplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells. The flow cytometric analyses suggested that SsnB arrests the cell cycle progression at G2-M phase in all neuroblastoma cell lines tested. Exposure of SsnB inhibited the compact spheroid formation and reduced the tumorigenicity of SH-SY5Y cells and SK-N-BE(2) cells in in vitro 3-D cell culture assays (anchorage-independent colony formation assay and hanging drop assay). SsnB lowers the cellular level of glutathione (GSH), increases generation of reactive oxygen species and activates the cleavage of caspase-3 whereas co-incubation of a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases the neuroblastoma cell viability. Our results for the first time demonstrate that SsnB possesses anticancer activity indicating that SsnB-induced reactive oxygen species generation promotes apoptotic cell death in neuroblastoma cells of different genetic background. Thus these data suggest that SsnB can be a promising drug candidate in neuroblastoma therapy." />
    <meta property="twitter:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0096343.g006&size=inline" />

<meta property="og:type" content="article" />
<meta property="og:url" content="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0096343"/>
<meta property="og:title" content="Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells"/>
<meta property="og:description" content="Neuroblastoma is one of the most common solid tumors and accounts for &sim;15% of all the cancer related deaths in the children. Despite the standard therapy for advanced disease including chemotherapy, surgery, and radiation, the mortality rate remains high for these patients. Hence, novel therapeutic agents are desperately needed. Here we examined the anticancer activity of a novel plant-derived compound, sparstolonin B (SsnB; 8,5&prime;-dihydroxy-4-phenyl-5,2&prime;-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was recently isolated from an aquatic Chinese herb, Sparganium stoloniferum, and tubers of this herb have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. Our cell viability and morphological analysis indicated that SsnB at 10 &micro;M concentration significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc nonamplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells. The flow cytometric analyses suggested that SsnB arrests the cell cycle progression at G2-M phase in all neuroblastoma cell lines tested. Exposure of SsnB inhibited the compact spheroid formation and reduced the tumorigenicity of SH-SY5Y cells and SK-N-BE(2) cells in in vitro 3-D cell culture assays (anchorage-independent colony formation assay and hanging drop assay). SsnB lowers the cellular level of glutathione (GSH), increases generation of reactive oxygen species and activates the cleavage of caspase-3 whereas co-incubation of a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases the neuroblastoma cell viability. Our results for the first time demonstrate that SsnB possesses anticancer activity indicating that SsnB-induced reactive oxygen species generation promotes apoptotic cell death in neuroblastoma cells of different genetic background. Thus these data suggest that SsnB can be a promising drug candidate in neuroblastoma therapy."/>
<meta property="og:image" content="https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0096343.g006&size=inline"/>

<meta name="citation_reference" content="citation_title=Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties;citation_author=Q Liang;citation_author=Q Wu;citation_author=J Jiang;citation_author=J Duan;citation_author=C Wang;citation_journal_title=J Biol Chem;citation_volume=286;citation_number=286;citation_first_page=26470;citation_last_page=26479;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells;citation_author=Q Liang;citation_author=F Yu;citation_author=X Cui;citation_author=J Duan;citation_author=Q Wu;citation_journal_title=Arch Pharm Res;citation_volume=36;citation_number=36;citation_first_page=890;citation_last_page=896;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=Sparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cells;citation_author=HR Bateman;citation_author=Q Liang;citation_author=D Fan;citation_author=V Rodriguez;citation_author=SM Lessner;citation_journal_title=PLoS One;citation_volume=8;citation_number=8;citation_first_page=e70500;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=A new alkaloid from the stem of Sparganium stoloniferum Buch.-Ham;citation_author=SX Li;citation_author=F Wang;citation_author=XH Deng;citation_author=SW Liang;citation_journal_title=J Asian Nat Prod Res;citation_volume=12;citation_number=12;citation_first_page=331;citation_last_page=333;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=New chemical constituents from the rhizomes of Sparganium stoloniferum;citation_author=Y Xiong;citation_author=KZ Deng;citation_author=YQ Guo;citation_author=WY Gao;citation_author=TJ Zhang;citation_journal_title=Arch Pharm Res;citation_volume=32;citation_number=32;citation_first_page=717;citation_last_page=720;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=A new phenylpropane glycoside from the rhizome of Sparganium stoloniferum;citation_author=SY Lee;citation_author=SU Choi;citation_author=JH Lee;citation_author=DU Lee;citation_author=KR Lee;citation_journal_title=Arch Pharm Res;citation_volume=33;citation_number=33;citation_first_page=515;citation_last_page=521;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Coumarins: old compounds with novel promising therapeutic perspectives;citation_author=ME Riveiro;citation_author=N De Kimpe;citation_author=A Moglioni;citation_author=R Vazquez;citation_author=F Monczor;citation_journal_title=Curr Med Chem;citation_volume=17;citation_number=17;citation_first_page=1325;citation_last_page=1338;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=The structure and pharmacological functions of coumarins and their derivatives;citation_author=L Wu;citation_author=X Wang;citation_author=W Xu;citation_author=F Farzaneh;citation_author=R Xu;citation_journal_title=Curr Med Chem;citation_volume=16;citation_number=16;citation_first_page=4236;citation_last_page=4260;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=Xanthone derivatives as potential anti-cancer drugs;citation_author=CN Lin;citation_author=SJ Liou;citation_author=TH Lee;citation_author=YC Chuang;citation_author=SJ Won;citation_journal_title=J Pharm Pharmacol;citation_volume=48;citation_number=48;citation_first_page=539;citation_last_page=544;citation_publication_date=1996;"/>    
<meta name="citation_reference" content="citation_title=Recent cancer drug development with xanthone structures;citation_author=Y Na;citation_journal_title=J Pharm Pharmacol;citation_volume=61;citation_number=61;citation_first_page=707;citation_last_page=712;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=Neuroblastoma: developmental biology, cancer genomics and immunotherapy;citation_author=NK Cheung;citation_author=MA Dyer;citation_journal_title=Nat Rev Cancer;citation_volume=13;citation_number=13;citation_first_page=397;citation_last_page=411;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=Neuroblastoma;citation_author=AM Davidoff;citation_journal_title=Semin Pediatr Surg;citation_volume=21;citation_number=21;citation_first_page=2;citation_last_page=14;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages;citation_author=V Ciccarone;citation_author=BA Spengler;citation_author=MB Meyers;citation_author=JL Biedler;citation_author=RA Ross;citation_journal_title=Cancer Res;citation_volume=49;citation_number=49;citation_first_page=219;citation_last_page=225;citation_publication_date=1989;"/>    
<meta name="citation_reference" content="citation_title=Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour;citation_author=M Schwab;citation_author=K Alitalo;citation_author=KH Klempnauer;citation_author=HE Varmus;citation_author=JM Bishop;citation_journal_title=Nature;citation_volume=305;citation_number=305;citation_first_page=245;citation_last_page=248;citation_publication_date=1983;"/>    
<meta name="citation_reference" content="citation_title=Molecular and genetic bases of neuroblastoma;citation_author=T Kamijo;citation_author=A Nakagawara;citation_journal_title=Int J Clin Oncol;citation_volume=17;citation_number=17;citation_first_page=190;citation_last_page=195;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Chromosomal aberrations in human neuroblastomas;citation_author=GM Brodeur;citation_author=G Sekhon;citation_author=MN Goldstein;citation_journal_title=Cancer;citation_volume=40;citation_number=40;citation_first_page=2256;citation_last_page=2263;citation_publication_date=1977;"/>    
<meta name="citation_reference" content="citation_title=Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines;citation_author=F Gilbert;citation_author=G Balaban;citation_author=P Moorhead;citation_author=D Bianchi;citation_author=H Schlesinger;citation_journal_title=Cancer Genet Cytogenet;citation_volume=7;citation_number=7;citation_first_page=33;citation_last_page=42;citation_publication_date=1982;"/>    
<meta name="citation_reference" content="citation_title=Human neuroblastomas and abnormalities of chromosomes 1 and 17;citation_author=F Gilbert;citation_author=M Feder;citation_author=G Balaban;citation_author=D Brangman;citation_author=DK Lurie;citation_journal_title=Cancer Res;citation_volume=44;citation_number=44;citation_first_page=5444;citation_last_page=5449;citation_publication_date=1984;"/>    
<meta name="citation_reference" content="citation_title=Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma;citation_author=ES Srivatsan;citation_author=V Murali;citation_author=RC Seeger;citation_journal_title=Prog Clin Biol Res;citation_volume=366;citation_number=366;citation_first_page=91;citation_last_page=98;citation_publication_date=1991;"/>    
<meta name="citation_reference" content="citation_title=Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification;citation_author=J Imamura;citation_author=CR Bartram;citation_author=F Berthold;citation_author=D Harms;citation_author=H Nakamura;citation_journal_title=Cancer Res;citation_volume=53;citation_number=53;citation_first_page=4053;citation_last_page=4058;citation_publication_date=1993;"/>    
<meta name="citation_reference" content="citation_title=Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas;citation_author=N Kawamata;citation_author=T Seriu;citation_author=HP Koeffler;citation_author=CR Bartram;citation_journal_title=Cancer;citation_volume=77;citation_number=77;citation_first_page=570;citation_last_page=575;citation_publication_date=1996;"/>    
<meta name="citation_reference" content="citation_title=No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma;citation_author=RM Hofstra;citation_author=NC Cheng;citation_author=C Hansen;citation_author=RP Stulp;citation_author=T Stelwagen;citation_journal_title=Hum Genet;citation_volume=97;citation_number=97;citation_first_page=362;citation_last_page=364;citation_publication_date=1996;"/>    
<meta name="citation_reference" content="citation_title=Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy;citation_author=DA Morgenstern;citation_author=S Baruchel;citation_author=MS Irwin;citation_journal_title=J Pediatr Hematol Oncol;citation_volume=35;citation_number=35;citation_first_page=337;citation_last_page=347;citation_publication_date=2013;"/>    
<meta name="citation_reference" content="citation_title=Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines;citation_author=N Sidell;citation_author=A Altman;citation_author=MR Haussler;citation_author=RC Seeger;citation_journal_title=Exp Cell Res;citation_volume=148;citation_number=148;citation_first_page=21;citation_last_page=30;citation_publication_date=1983;"/>    
<meta name="citation_reference" content="citation_title=Tissue Transglutaminase Mediates Activation of RhoA and MAP Kinase Pathways during Retinoic Acid-induced Neuronal Differentiation of SH-SY5Y Cells;citation_author=US Singh;citation_author=J Pan;citation_author=YL Kao;citation_author=S Joshi;citation_author=KL Young;citation_journal_title=J Biol Chem;citation_volume=278;citation_number=278;citation_first_page=391;citation_last_page=399;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma;citation_author=CJ Thiele;citation_author=CP Reynolds;citation_author=MA Israel;citation_journal_title=Nature;citation_volume=313;citation_number=313;citation_first_page=404;citation_last_page=406;citation_publication_date=1985;"/>    
<meta name="citation_reference" content="citation_title=Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation;citation_author=S Joshi;citation_author=RS Guleria;citation_author=J Pan;citation_author=D Dipette;citation_author=US Singh;citation_journal_title=Biochim Biophys Acta;citation_volume=1772;citation_number=1,772;citation_first_page=1093;citation_last_page=1102;citation_publication_date=2007;"/>    
<meta name="citation_reference" content="citation_title=Multiple defects of the nerve growth factor receptor in human neuroblastomas;citation_author=CG Azar;citation_author=NJ Scavarda;citation_author=CP Reynolds;citation_author=GM Brodeur;citation_journal_title=Cell Growth Differ;citation_volume=1;citation_number=1;citation_first_page=421;citation_last_page=428;citation_publication_date=1990;"/>    
<meta name="citation_reference" content="citation_title=Analysis of cell cycle by flow cytometry;citation_author=P Pozarowski;citation_author=Z Darzynkiewicz;citation_journal_title=Methods Mol Biol;citation_volume=281;citation_number=281;citation_first_page=301;citation_last_page=311;citation_publication_date=2004;"/>    
<meta name="citation_reference" content="citation_title=Ethanol impairs activation of retinoic acid receptors in cerebellar granule cells in a rodent model of fetal alcohol spectrum disorders;citation_author=A Kumar;citation_author=CK Singh;citation_author=DD DiPette;citation_author=US Singh;citation_journal_title=Alcohol Clin Exp Res;citation_volume=34;citation_number=34;citation_first_page=928;citation_last_page=937;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=What does the commonly used DCF test for oxidative stress really show?;citation_author=M Karlsson;citation_author=T Kurz;citation_author=UT Brunk;citation_author=SE Nilsson;citation_author=CI Frennesson;citation_journal_title=Biochem J;citation_volume=428;citation_number=428;citation_first_page=183;citation_last_page=190;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders;citation_author=A Kumar;citation_author=CK Singh;citation_author=HA Lavoie;citation_author=DJ Dipette;citation_author=US Singh;citation_journal_title=Mol Pharmacol;citation_volume=80;citation_number=80;citation_first_page=446;citation_last_page=457;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity;citation_author=H Zhang;citation_author=P Limphong;citation_author=J Pieper;citation_author=Q Liu;citation_author=CK Rodesch;citation_journal_title=FASEB J;citation_volume=26;citation_number=26;citation_first_page=1442;citation_last_page=1451;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line;citation_author=FB Baumann Kubetzko;citation_author=C Di Paolo;citation_author=C Maag;citation_author=R Meier;citation_author=BW Schafer;citation_journal_title=Carcinogenesis;citation_volume=25;citation_number=25;citation_first_page=1839;citation_last_page=1846;citation_publication_date=2004;"/>    
<meta name="citation_reference" content="citation_title=Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype;citation_author=KL Sodek;citation_author=MJ Ringuette;citation_author=TJ Brown;citation_journal_title=Int J Cancer;citation_volume=124;citation_number=124;citation_first_page=2060;citation_last_page=2070;citation_publication_date=2009;"/>    
<meta name="citation_reference" content="citation_title=Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells;citation_author=J Du;citation_author=DH Daniels;citation_author=C Asbury;citation_author=S Venkataraman;citation_author=J Liu;citation_journal_title=J Biol Chem;citation_volume=281;citation_number=281;citation_first_page=37416;citation_last_page=37426;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen species;citation_author=L Yin;citation_author=T Ohno;citation_author=R Weichselbaum;citation_author=S Kharbanda;citation_author=D Kufe;citation_journal_title=Mol Cancer Ther;citation_volume=1;citation_number=1;citation_first_page=43;citation_last_page=48;citation_publication_date=2001;"/>    
<meta name="citation_reference" content="citation_title=Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation;citation_author=O Myhre;citation_author=JM Andersen;citation_author=H Aarnes;citation_author=F Fonnum;citation_journal_title=Biochem Pharmacol;citation_volume=65;citation_number=65;citation_first_page=1575;citation_last_page=1582;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Cellular response to oxidative stress: signaling for suicide and survival;citation_author=JL Martindale;citation_author=NJ Holbrook;citation_journal_title=J Cell Physiol;citation_volume=192;citation_number=192;citation_first_page=1;citation_last_page=15;citation_publication_date=2002;"/>    
<meta name="citation_reference" content="citation_title=Recent advances in apoptosis, mitochondria and drug resistance in cancer cells;citation_author=IR Indran;citation_author=G Tufo;citation_author=S Pervaiz;citation_author=C Brenner;citation_journal_title=Biochim Biophys Acta;citation_volume=1807;citation_number=1,807;citation_first_page=735;citation_last_page=745;citation_publication_date=2011;"/>    
<meta name="citation_reference" content="citation_title=Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage;citation_author=GM Brodeur;citation_author=RC Seeger;citation_author=M Schwab;citation_author=HE Varmus;citation_author=JM Bishop;citation_journal_title=Science;citation_volume=224;citation_number=224;citation_first_page=1121;citation_last_page=1124;citation_publication_date=1984;"/>    
<meta name="citation_reference" content="citation_title=Molecular mechanisms of N-acetylcysteine actions;citation_author=M Zafarullah;citation_author=WQ Li;citation_author=J Sylvester;citation_author=M Ahmad;citation_journal_title=Cell Mol Life Sci;citation_volume=60;citation_number=60;citation_first_page=6;citation_last_page=20;citation_publication_date=2003;"/>    
<meta name="citation_reference" content="citation_title=Towards a turning point of neuroblastoma therapy;citation_author=GP Tonini;citation_author=A Nakagawara;citation_author=F Berthold;citation_journal_title=Cancer Lett;citation_volume=326;citation_number=326;citation_first_page=128;citation_last_page=134;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Promising therapeutic targets in neuroblastoma;citation_author=KK Matthay;citation_author=RE George;citation_author=AL Yu;citation_journal_title=Clin Cancer Res;citation_volume=18;citation_number=18;citation_first_page=2740;citation_last_page=2753;citation_publication_date=2012;"/>    
<meta name="citation_reference" content="citation_title=Anticancer drug targets: cell cycle and checkpoint control;citation_author=GI Shapiro;citation_author=JW Harper;citation_journal_title=J Clin Invest;citation_volume=104;citation_number=104;citation_first_page=1645;citation_last_page=1653;citation_publication_date=1999;"/>    
<meta name="citation_reference" content="citation_title=Regulation of the G2/M transition by p53;citation_author=WR Taylor;citation_author=GR Stark;citation_journal_title=Oncogene;citation_volume=20;citation_number=20;citation_first_page=1803;citation_last_page=1815;citation_publication_date=2001;"/>    
<meta name="citation_reference" content="citation_title=Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma;citation_author=M Schwab;citation_author=J Ellison;citation_author=M Busch;citation_author=W Rosenau;citation_author=HE Varmus;citation_journal_title=Proc Natl Acad Sci U S A;citation_volume=81;citation_number=81;citation_first_page=4940;citation_last_page=4944;citation_publication_date=1984;"/>    
<meta name="citation_reference" content="citation_title=Targeted expression of MYCN causes neuroblastoma in transgenic mice;citation_author=WA Weiss;citation_author=K Aldape;citation_author=G Mohapatra;citation_author=BG Feuerstein;citation_author=JM Bishop;citation_journal_title=Embo J;citation_volume=16;citation_number=16;citation_first_page=2985;citation_last_page=2995;citation_publication_date=1997;"/>    
<meta name="citation_reference" content="citation_title=MYCN oncoprotein targets and their therapeutic potential;citation_author=E Bell;citation_author=L Chen;citation_author=T Liu;citation_author=GM Marshall;citation_author=J Lunec;citation_journal_title=Cancer Lett;citation_volume=293;citation_number=293;citation_first_page=144;citation_last_page=157;citation_publication_date=2010;"/>    
<meta name="citation_reference" content="citation_title=MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells;citation_author=JH Kang;citation_author=PG Rychahou;citation_author=TA Ishola;citation_author=J Qiao;citation_author=BM Evers;citation_journal_title=Biochem Biophys Res Commun;citation_volume=351;citation_number=351;citation_first_page=192;citation_last_page=197;citation_publication_date=2006;"/>    
<meta name="citation_reference" content="citation_title=Cellular stress response and apoptosis in cancer therapy;citation_author=I Herr;citation_author=KM Debatin;citation_journal_title=Blood;citation_volume=98;citation_number=98;citation_first_page=2603;citation_last_page=2614;citation_publication_date=2001;"/>    


<!-- DoubleClick overall ad setup script -->
<script type='text/javascript'>
  var googletag = googletag || {};
  googletag.cmd = googletag.cmd || [];
  (function() {
    var gads = document.createElement('script');
    gads.async = true;
    gads.type = 'text/javascript';
    var useSSL = 'https:' == document.location.protocol;
    gads.src = (useSSL ? 'https:' : 'http:') +
        '//www.googletagservices.com/tag/js/gpt.js';
    var node = document.getElementsByTagName('script')[0];
    node.parentNode.insertBefore(gads, node);
  })();
</script>

<!-- DoubleClick ad slot setup script -->

  <script id="doubleClickSetupScript" type='text/javascript'>
    googletag.cmd.push(function() {
  googletag.defineSlot('/75507958/PONE_728x90_ATF', [728, 90], 'div-gpt-ad-1458247671871-0').addService(googletag.pubads());
  googletag.defineSlot('/75507958/PONE_160x600_BTF', [160, 600], 'div-gpt-ad-1458247671871-1').addService(googletag.pubads());
      var personalizedAds = window.plosCookieConsent && window.plosCookieConsent.hasConsented('advertising');
      googletag.pubads().setRequestNonPersonalizedAds(personalizedAds ? 0 : 1);
      googletag.pubads().enableSingleRequest();
      googletag.enableServices();
    });
  </script>



<script type="text/javascript">
    var WombatConfig = WombatConfig || {};
    WombatConfig.journalKey = "PLoSONE";
    WombatConfig.figurePath = "/plosone/article/figure/image";
    WombatConfig.figShareInstitutionString = "plos";
    WombatConfig.doiResolverPrefix = "https://dx.plos.org/";
</script>

<script type="text/javascript">
  var WombatConfig = WombatConfig || {};
  WombatConfig.metrics = WombatConfig.metrics || {};
  WombatConfig.metrics.referenceUrl      = "http://lagotto.io/plos";
  WombatConfig.metrics.googleScholarUrl  = "https://scholar.google.com/scholar";
  WombatConfig.metrics.googleScholarCitationUrl  = WombatConfig.metrics.googleScholarUrl + "?hl=en&lr=&q=";
  WombatConfig.metrics.crossrefUrl  = "https://www.crossref.org";
</script>
<script defer="defer" src="/resource/js/defer.js?df22e765dd76f625eb58"></script><script src="/resource/js/sync.js?df22e765dd76f625eb58"></script>
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.4/jquery.min.js"></script>

          <script type="text/javascript" src="https://widgets.figshare.com/static/figshare.js"></script>

<script src="/resource/js/vendor/fastclick/lib/fastclick.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.js" type="text/javascript"></script>
<script src="/resource/js/vendor/underscore-min.js" type="text/javascript"></script>
<script src="/resource/js/vendor/underscore.string.min.js" type="text/javascript"></script>
<script src="/resource/js/vendor/moment.js" type="text/javascript"></script>


<script src="/resource/js/vendor/jquery-ui-effects.min.js" type="text/javascript"></script>

<script src="/resource/js/vendor/foundation/foundation.tooltip.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.tab.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.reveal.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.slider.js" type="text/javascript"></script>

<script src="/resource/js/util/utils.js" type="text/javascript"></script>
<script src="/resource/js/components/toggle.js" type="text/javascript"></script>
<script src="/resource/js/components/truncate_elem.js" type="text/javascript"></script>
<script src="/resource/js/components/tooltip_hover.js" type="text/javascript"></script>
<script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>

<!--For Google Tag manager to be able to track site information  -->
<script>

  dataLayer = [{
    'mobileSite': 'false',
    'desktopSite': 'true'
  }];

</script>

</head>

<body class="article plosone">


<!-- Google Tag Manager -->
<script>
  var gaDisable = 'ga-disable-UA-76325259-';
  var consented = !(window.plosCookieConsent && window.plosCookieConsent.hasConsented('analytics'));
  for(var i=0;i<100;i++) { //This will break if we ever support 100+ journals (*insert Oh no! Anyway... meme*)
    window[gaDisable + i] = consented;
  }
</script>
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-TP26BH"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>
  (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-TP26BH');
</script>

<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQQMGF"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    '//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-MQQMGF');</script>
<!-- End Google Tag Manager -->

<!-- New Relic -->
<script type="text/javascript">
  ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}};
  window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{s.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(32),s={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(s.console=!0,o.indexOf("dev")!==-1&&(s.dev=!0),o.indexOf("nr_dev")!==-1&&(s.nrDev=!0))}catch(c){}s.nrDev&&i.on("internal-error",function(t){r(t.stack)}),s.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),s.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(s,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,s){try{l?l-=1:o(s||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,c.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:c.now();i("err",[t,n])}var i=t("handle"),a=t(33),s=t("ee"),c=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError";if(!c.disabled){var l=0;c.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(14),t(13),"addEventListener"in window&&t(7),c.xhrWrappable&&t(15),d=!0)}s.on("fn-start",function(t,e,n){d&&(l+=1)}),s.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),s.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),s.on("internal-error",function(t){i("ierr",[t,c.now(),!0])})}},{}],3:[function(t,e,n){var r=t("loader");r.disabled||(r.features.ins=!0)},{}],4:[function(t,e,n){function r(){U++,L=g.hash,this[u]=y.now()}function o(){U--,g.hash!==L&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var s="-start",c="-end",f="-body",u="fn"+s,d="fn"+c,p="cb"+s,l="cb"+c,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable&&!y.disabled){var x=t(11),b=t(12),E=t(9),R=t(7),O=t(14),T=t(8),P=t(15),S=t(10),M=t("ee"),N=M.get("tracer"),C=t(23);t(17),y.features.spa=!0;var L,U=0;M.on(u,r),b.on(p,r),S.on(p,r),M.on(d,o),b.on(l,o),S.on(l,o),M.buffer([u,d,"xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+c,"clearTimeout"+s,u]),P.buffer([u,"new-xhr","send-xhr"+s]),T.buffer([m+s,m+"-done",m+f+s,m+f+c]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+s]),N.buffer([u,"no-"+u]),S.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(T,m+s),a(T,m+"-done"),a(S,"new-jsonp"),a(S,"jsonp-end"),a(S,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,C(!0)),w[v]("load",i,C(!0)),w[v]("popstate",function(){i(0,U>1)},C(!0))}},{}],5:[function(t,e,n){function r(){var t=new PerformanceObserver(function(t,e){var n=t.getEntries();s(v,[n])});try{t.observe({entryTypes:["resource"]})}catch(e){}}function o(t){if(s(v,[window.performance.getEntriesByType(w)]),window.performance["c"+p])try{window.performance[h](m,o,!1)}catch(t){}else try{window.performance[h]("webkit"+m,o,!1)}catch(t){}}function i(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var a=t("ee"),s=t("handle"),c=t(14),f=t(13),u=t(6),d=t(23),p="learResourceTimings",l="addEventListener",h="removeEventListener",m="resourcetimingbufferfull",v="bstResource",w="resource",g="-start",y="-end",x="fn"+g,b="fn"+y,E="bstTimer",R="pushState",O=t("loader");if(!O.disabled){O.features.stn=!0,t(9),"addEventListener"in window&&t(7);var T=NREUM.o.EV;a.on(x,function(t,e){var n=t[0];n instanceof T&&(this.bstStart=O.now())}),a.on(b,function(t,e){var n=t[0];n instanceof T&&s("bst",[n,e,this.bstStart,O.now()])}),c.on(x,function(t,e,n){this.bstStart=O.now(),this.bstType=n}),c.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),this.bstType])}),f.on(x,function(){this.bstStart=O.now()}),f.on(b,function(t,e){s(E,[e,this.bstStart,O.now(),"requestAnimationFrame"])}),a.on(R+g,function(t){this.time=O.now(),this.startPath=location.pathname+location.hash}),a.on(R+y,function(t){s("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),u()?(s(v,[window.performance.getEntriesByType("resource")]),r()):l in window.performance&&(window.performance["c"+p]?window.performance[l](m,o,d(!1)):window.performance[l]("webkit"+m,o,d(!1))),document[l]("scroll",i,d(!1)),document[l]("keypress",i,d(!1)),document[l]("click",i,d(!1))}}},{}],6:[function(t,e,n){e.exports=function(){return"PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver}},{}],7:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){s.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),s=t("wrap-function")(a,!0),c=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var r=c(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?s(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],8:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var s=r.apply(this,t);return o.emit(n+"start",[t,a],s),s.then(function(t){return o.emit(n+"end",[null,t],s),t},function(t){throw o.emit(n+"end",[t],s),t})})}var o=t("ee").get("fetch"),i=t(33),a=t(32);e.exports=o;var s=window,c="fetch-",f=c+"body-",u=["arrayBuffer","blob","json","text","formData"],d=s.Request,p=s.Response,l=s.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(s,"fetch",c),o.on(c+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(c+"done",[null,e],n)}else o.emit(c+"done",[t],n)}))},{}],9:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],10:[function(t,e,n){function r(t){function e(){f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}function n(){f.emit("jsonp-error",[],l),f.emit("jsonp-end",[],l),t.removeEventListener("load",e,c(!1)),t.removeEventListener("error",n,c(!1))}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var d=s(a),p="function"==typeof d.parent[d.key];if(p){var l={};u.inPlace(d.parent,[d.key],"cb-",l),t.addEventListener("load",e,c(!1)),t.addEventListener("error",n,c(!1)),f.emit("new-jsonp",[t.src],l)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(d);return e?e[1]:null}function a(t,e){var n=t.match(l),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function s(t){var e=t.match(p);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var c=t(23),f=t("ee").get("jsonp"),u=t("wrap-function")(f);if(e.exports=f,o()){var d=/[?&](?:callback|cb)=([^&#]+)/,p=/(.*)\.([^.]+)/,l=/^(\w+)(\.|$)(.*)$/,h=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?u.inPlace(Node.prototype,h,"dom-"):(u.inPlace(HTMLElement.prototype,h,"dom-"),u.inPlace(HTMLHeadElement.prototype,h,"dom-"),u.inPlace(HTMLBodyElement.prototype,h,"dom-")),f.on("dom-start",function(t){r(t[0])})}},{}],11:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],12:[function(t,e,n){function r(t){var e=i.context(),n=s(t,"executor-",e,null,!1),r=new f(n);return i.context(r).getCtx=function(){return e},r}var o=t("wrap-function"),i=t("ee").get("promise"),a=t("ee").getOrSetContext,s=o(i),c=t(32),f=NREUM.o.PR;e.exports=i,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){i.emit("propagate",[null,!o],a,!1,!1),o=o||!t}}var o=!1;c(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var a=e.apply(f,arguments),s=f.resolve(a);return s}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&i.emit("propagate",[t,!0],n,!1,!1),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),c(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),o.wrapInPlace(f.prototype,"then",function(t){return function(){var e=this,n=o.argsToArray.apply(this,arguments),r=a(e);r.promise=e,n[0]=s(n[0],"cb-",r,null,!1),n[1]=s(n[1],"cb-",r,null,!1);var c=t.apply(this,n);return r.nextPromise=c,i.emit("propagate",[e,!0],c,!1,!1),c}}),i.on("executor-start",function(t){t[0]=s(t[0],"resolve-",this,null,!1),t[1]=s(t[1],"resolve-",this,null,!1)}),i.on("executor-err",function(t,e,n){t[1](n)}),i.on("cb-end",function(t,e,n){i.emit("propagate",[n,!0],this.nextPromise,!1,!1)}),i.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=i.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],13:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],14:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),s="setTimeout",c="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[s,"setImmediate"],s+d),a.inPlace(window,[c],c+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(c+u,r),i.on(s+u,o)},{}],15:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",s)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,y,"fn-",s)}function i(t){x.push(t),m&&(E?E.then(a):w?w(a):(R=-R,O.data=R))}function a(){for(var t=0;t<x.length;t++)r([],x[t]);x.length&&(x=[])}function s(t,e){return e}function c(t,e){for(var n in t)e[n]=t[n];return e}t(7);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=t(23),l=NREUM.o,h=l.XHR,m=l.MO,v=l.PR,w=l.SI,g="readystatechange",y=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],x=[];e.exports=u;var b=window.XMLHttpRequest=function(t){var e=new h(t);try{u.emit("new-xhr",[e],e),e.addEventListener(g,o,p(!1))}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(c(h,b),b.prototype=h.prototype,d.inPlace(b.prototype,["open","send"],"-xhr-",s),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),m){var E=v&&v.resolve();if(!w&&!v){var R=1,O=document.createTextNode(R);new m(a).observe(O,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===g||a()})},{}],16:[function(t,e,n){function r(t){if(!s(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||c(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&c(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",s=1,c="",f="";return o+"@nr="+i+"-"+s+"-"+n+"-"+r+"-"+t+"-"+a+"-"+c+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var s={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(s.d.tk=i),btoa(JSON.stringify(s))}function s(t){return f()&&c(t)}function c(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(29),h=t(18);e.exports={generateTracePayload:r,shouldGenerateTrace:s}},{}],17:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,s("xhr",[e,n,this.startTime,this.endTime,"xhr"],this))}}function o(t,e){var n=c(e),r=t.params;r.hostname=n.hostname,r.port=n.port,r.protocol=n.protocol,r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=n,t.sameOrigin=n.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable&&!a.disabled){var s=t("handle"),c=t(18),f=t(16).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(24),m=t(22),v=t(19),w=t(23),g=NREUM.o.REQ,y=window.XMLHttpRequest;a.features.xhr=!0,t(15),t(8),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,e.params=this.params||{},e.metrics=this.metrics||{},t.addEventListener("load",function(n){i(e,t)},w(!1)),h&&(h>34||h<10)||t.addEventListener("progress",function(t){e.lastSize=t.loaded},w(!1))}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var s=0;s<p;s++)e.addEventListener(d[s],this.listener,w(!1))}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("xhr-resolved",function(){this.endTime=a.now()}),u.on("addEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof y&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof y&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url?n=t[0].url:window.URL&&t[0]&&t[0]instanceof URL&&(n=t[0].href),n&&(this.parsedOrigin=c(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]||window.URL&&t[0]&&t[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)}),u.on("fetch-start",function(t,e){this.params={},this.metrics={},this.startTime=a.now(),this.dt=e,t.length>=1&&(this.target=t[0]),t.length>=2&&(this.opts=t[1]);var n,r=this.opts||{},i=this.target;"string"==typeof i?n=i:"object"==typeof i&&i instanceof g?n=i.url:window.URL&&"object"==typeof i&&i instanceof URL&&(n=i.href),o(this,n);var s=(""+(i&&i instanceof g&&i.method||r.method||"GET")).toUpperCase();this.params.method=s,this.txSize=m(r.body)||0}),u.on("fetch-done",function(t,e){this.endTime=a.now(),this.params||(this.params={}),this.params.status=e?e.status:0;var n;"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var r={txSize:this.txSize,rxSize:n,duration:a.now()-this.startTime};s("xhr",[this.params,r,this.startTime,this.endTime,"fetch"],this)})}},{}],18:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,s=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||s),"/"===o.pathname&&(r[t]=o),o}},{}],19:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(22);e.exports=r},{}],20:[function(t,e,n){function r(){}function o(t,e,n,r){return function(){return u.recordSupportability("API/"+e+"/called"),i(t+e,[f.now()].concat(s(arguments)),n?null:this,r),n?void 0:this}}var i=t("handle"),a=t(32),s=t(33),c=t("ee").get("tracer"),f=t("loader"),u=t(25),d=NREUM;"undefined"==typeof window.newrelic&&(newrelic=d);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",h=l+"ixn-";a(p,function(t,e){d[e]=o(l,e,!0,"api")}),d.addPageAction=o(l,"addPageAction",!0),d.setCurrentRouteName=o(l,"routeName",!0),e.exports=newrelic,d.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(h+"tracer",[f.now(),t,n],r),function(){if(c.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw c.emit("fn-err",[arguments,this,t],n),t}finally{c.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){m[e]=o(h,e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),u.recordSupportability("API/noticeError/called"),i("err",[t,f.now(),!1,e])}},{}],21:[function(t,e,n){function r(t){if(NREUM.init){for(var e=NREUM.init,n=t.split("."),r=0;r<n.length-1;r++)if(e=e[n[r]],"object"!=typeof e)return;return e=e[n[n.length-1]]}}e.exports={getConfiguration:r}},{}],22:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],23:[function(t,e,n){var r=!1;try{var o=Object.defineProperty({},"passive",{get:function(){r=!0}});window.addEventListener("testPassive",null,o),window.removeEventListener("testPassive",null,o)}catch(i){}e.exports=function(t){return r?{passive:!0,capture:!!t}:!!t}},{}],24:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],25:[function(t,e,n){function r(t,e){var n=[a,t,{name:t},e];return i("storeMetric",n,null,"api"),n}function o(t,e){var n=[s,t,{name:t},e];return i("storeEventMetrics",n,null,"api"),n}var i=t("handle"),a="sm",s="cm";e.exports={constants:{SUPPORTABILITY_METRIC:a,CUSTOM_METRIC:s},recordSupportability:r,recordCustom:o}},{}],26:[function(t,e,n){function r(){return s.exists&&performance.now?Math.round(performance.now()):(i=Math.max((new Date).getTime(),i))-a}function o(){return i}var i=(new Date).getTime(),a=i,s=t(34);e.exports=r,e.exports.offset=a,e.exports.getLastTimestamp=o},{}],27:[function(t,e,n){function r(t){return!(!t||!t.protocol||"file:"===t.protocol)}e.exports=r},{}],28:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?p("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&p("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();if(n.length>0){var r=n[n.length-1];if(c&&c<r.startTime)return;p("lcp",[r])}}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||p("cls",[t])})}function a(t){if(t instanceof v&&!g){var e=Math.round(t.timeStamp),n={type:t.type};e<=l.now()?n.fid=l.now()-e:e>l.offset&&e<=Date.now()?(e-=l.offset,n.fid=l.now()-e):e=l.now(),g=!0,p("timing",["fi",e,n])}}function s(t){"hidden"===t&&(c=l.now(),p("pageHide",[c]))}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var c,f,u,d,p=t("handle"),l=t("loader"),h=t(31),m=t(23),v=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){f=new PerformanceObserver(r);try{f.observe({entryTypes:["paint"]})}catch(w){}u=new PerformanceObserver(o);try{u.observe({entryTypes:["largest-contentful-paint"]})}catch(w){}d=new PerformanceObserver(i);try{d.observe({type:"layout-shift",buffered:!0})}catch(w){}}if("addEventListener"in document){var g=!1,y=["click","keydown","mousedown","pointerdown","touchstart"];y.forEach(function(t){document.addEventListener(t,a,m(!1))})}h(s)}},{}],29:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",s=0;s<i.length;s++)o=i[s],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],30:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var s=navigator.userAgent,c=s.match(a);c&&s.indexOf("Chrome")===-1&&s.indexOf("Chromium")===-1&&(o="Safari",i=c[1])}e.exports={agent:o,version:i,match:r}},{}],31:[function(t,e,n){function r(t){function e(){t(s&&document[s]?document[s]:document[i]?"hidden":"visible")}"addEventListener"in document&&a&&document.addEventListener(a,e,o(!1))}var o=t(23);e.exports=r;var i,a,s;"undefined"!=typeof document.hidden?(i="hidden",a="visibilitychange",s="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",a="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(i="webkitHidden",a="webkitvisibilitychange",s="webkitVisibilityState")},{}],32:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],33:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],34:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?f(t,c,a):a()}function n(n,r,o,i,a){if(a!==!1&&(a=!0),!l.aborted||i){t&&a&&t(n,r,o);for(var s=e(o),c=m(n),f=c.length,u=0;u<f;u++)c[u].apply(s,r);var p=d[y[n]];return p&&p.push([x,n,r,s]),s}}function i(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return p[t]=p[t]||o(n)}function w(t,e){l.aborted||u(t,function(t,n){e=e||"feature",y[n]=e,e in d||(d[e]=[])})}var g={},y={},x={on:i,addEventListener:i,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:s,aborted:!1};return x}function i(t){return f(t,c,a)}function a(){return new r}function s(){(d.api||d.feature)&&(l.aborted=!0,d=l.backlog={})}var c="nr@context",f=t("gos"),u=t(32),d={},p={},l=e.exports=o();e.exports.getOrSetContext=i,l.backlog=d},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!P++){var t=T.info=NREUM.info,e=v.getElementsByTagName("script")[0];if(setTimeout(f.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return f.abort();c(R,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+T.offset],null,"api"),s("timing",["load",n]);var r=v.createElement("script");0===t.agent.indexOf("http://")||0===t.agent.indexOf("https://")?r.src=t.agent:r.src=h+"://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===v.readyState&&i()}function i(){s("mark",["domContent",a()+T.offset],null,"api")}var a=t(26),s=t("handle"),c=t(32),f=t("ee"),u=t(30),d=t(27),p=t(21),l=t(23),h=p.getConfiguration("ssl")===!1?"http":"https",m=window,v=m.document,w="addEventListener",g="attachEvent",y=m.XMLHttpRequest,x=y&&y.prototype,b=!d(m.location);NREUM.o={ST:setTimeout,SI:m.setImmediate,CT:clearTimeout,XHR:y,REQ:m.Request,EV:m.Event,PR:m.Promise,MO:m.MutationObserver};var E=""+location,R={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1212.min.js"},O=y&&x&&x[w]&&!/CriOS/.test(navigator.userAgent),T=e.exports={offset:a.getLastTimestamp(),now:a,origin:E,features:{},xhrWrappable:O,userAgent:u,disabled:b};if(!b){t(20),t(28),v[w]?(v[w]("DOMContentLoaded",i,l(!1)),m[w]("load",r,l(!1))):(v[g]("onreadystatechange",o),m[g]("onload",r)),s("mark",["firstbyte",a.getLastTimestamp()],null,"api");var P=0}},{}],"wrap-function":[function(t,e,n){function r(t,e){function n(e,n,r,c,f){function nrWrapper(){var i,a,u,p;try{a=this,i=d(arguments),u="function"==typeof r?r(i,a):r||{}}catch(l){o([l,"",[i,a,c],u],t)}s(n+"start",[i,a,c],u,f);try{return p=e.apply(a,i)}catch(h){throw s(n+"err",[i,a,h],u,f),h}finally{s(n+"end",[i,a,p],u,f)}}return a(e)?e:(n||(n=""),nrWrapper[p]=e,i(e,nrWrapper,t),nrWrapper)}function r(t,e,r,o,i){r||(r="");var s,c,f,u="-"===r.charAt(0);for(f=0;f<e.length;f++)c=e[f],s=t[c],a(s)||(t[c]=n(s,u?c+r:r,o,c,i))}function s(n,r,i,a){if(!h||e){var s=h;h=!0;try{t.emit(n,r,i,e,a)}catch(c){o([c,n,r,i],t)}h=s}}return t||(t=u),n.inPlace=r,n.flag=p,n}function o(t,e){e||(e=u);try{e.emit("internal-error",t)}catch(n){}}function i(t,e,n){if(Object.defineProperty&&Object.keys)try{var r=Object.keys(t);return r.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(i){o([i],n)}for(var a in t)l.call(t,a)&&(e[a]=t[a]);return e}function a(t){return!(t&&t instanceof Function&&t.apply&&!t[p])}function s(t,e){var n=e(t);return n[p]=t,i(t,n,u),n}function c(t,e,n){var r=t[e];t[e]=s(r,n)}function f(){for(var t=arguments.length,e=new Array(t),n=0;n<t;++n)e[n]=arguments[n];return e}var u=t("ee"),d=t(33),p="nr@original",l=Object.prototype.hasOwnProperty,h=!1;e.exports=r,e.exports.wrapFunction=s,e.exports.wrapInPlace=c,e.exports.argsToArray=f},{}]},{},["loader",2,17,5,3,4]);
  ;NREUM.loader_config={accountID:"804283",trustKey:"804283",agentID:"402703674",licenseKey:"cf99e8d2a3",applicationID:"402703674"}
  ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"cf99e8d2a3",
    // Modified this value from the generated script, to pass prod vs dev
    applicationID: window.location.hostname.includes('journals.plos.org') ? "402703674" : "402694889",
    sa:1}
</script>
<!-- End New Relic -->






<header>
  <div id="topslot" class="head-top">

<div class="center">
<div class="title">Advertisement</div>
<!-- DoubleClick Ad Zone -->
  <div class='advertisement' id='div-gpt-ad-1458247671871-0' style='width:728px; height:90px;'>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-0'); });
    </script>
  </div>
</div>
  </div>

  <div id="user" class="nav" data-user-management-url="https://community.plos.org">
  </div>
  <div id="pagehdr">

    <nav class="nav-main">




<h1 class="logo">
  <a href="/plosone/.">PLOS ONE</a>
</h1>

<section class="top-bar-section"> 

<ul class="nav-elements">


    <li class="multi-col-parent menu-section-header has-dropdown" id="publish">
    Publish
      <div class="dropdown mega ">
        <ul class="multi-col" id="publish-dropdown-list">

  <li class="menu-section-header " id="submissions">
    <span class="menu-section-header-title">  Submissions </span>

    <ul class="menu-section "
        id="submissions-dropdown-list">
      <li>
    <a href="/plosone/s/getting-started" >Getting Started</a>
  </li>

      <li>
    <a href="/plosone/s/submission-guidelines" >Submission Guidelines</a>
  </li>

      <li>
    <a href="/plosone/s/figures" >Figures</a>
  </li>

      <li>
    <a href="/plosone/s/tables" >Tables</a>
  </li>

      <li>
    <a href="/plosone/s/supporting-information" >Supporting Information</a>
  </li>

      <li>
    <a href="/plosone/s/latex" >LaTeX</a>
  </li>

      <li>
    <a href="/plosone/s/what-we-publish" >What We Publish</a>
  </li>

      <li>
    <a href="/plosone/s/preprints" >Preprints</a>
  </li>

      <li>
    <a href="/plosone/s/revising-your-manuscript" >Revising Your Manuscript</a>
  </li>

      <li>
    <a href="/plosone/s/submit-now" >Submit Now</a>
  </li>

      <li>
    <a href="https://collections.plos.org/s/calls-for-papers" >Calls for Papers</a>
  </li>

    </ul>

  </li>


  <li class="menu-section-header " id="policies">
    <span class="menu-section-header-title">  Policies </span>

    <ul class="menu-section "
        id="policies-dropdown-list">
      <li>
    <a href="/plosone/s/best-practices-in-research-reporting" >Best Practices in Research Reporting</a>
  </li>

      <li>
    <a href="/plosone/s/human-subjects-research" >Human Subjects Research</a>
  </li>

      <li>
    <a href="/plosone/s/animal-research" >Animal Research</a>
  </li>

      <li>
    <a href="/plosone/s/competing-interests" >Competing Interests</a>
  </li>

      <li>
    <a href="/plosone/s/disclosure-of-funding-sources" >Disclosure of Funding Sources</a>
  </li>

      <li>
    <a href="/plosone/s/licenses-and-copyright" >Licenses and Copyright</a>
  </li>

      <li>
    <a href="/plosone/s/data-availability" >Data Availability</a>
  </li>

      <li>
    <a href="/plosone/s/complementary-research" >Complementary Research</a>
  </li>

      <li>
    <a href="/plosone/s/materials-software-and-code-sharing" >Materials, Software and Code Sharing</a>
  </li>

      <li>
    <a href="/plosone/s/ethical-publishing-practice" >Ethical Publishing Practice</a>
  </li>

      <li>
    <a href="/plosone/s/authorship" >Authorship</a>
  </li>

      <li>
    <a href="/plosone/s/corrections-expressions-of-concern-and-retractions" >Corrections, Expressions of Concern, and Retractions</a>
  </li>

    </ul>

  </li>


  <li class="menu-section-header " id="manuscript-review-and-publication">
    <span class="menu-section-header-title">  Manuscript Review and Publication </span>

    <ul class="menu-section "
        id="manuscript-review-and-publication-dropdown-list">
      <li>
    <a href="/plosone/s/criteria-for-publication" >Criteria for Publication</a>
  </li>

      <li>
    <a href="/plosone/s/editorial-and-peer-review-process" >Editorial and Peer Review Process</a>
  </li>

      <li>
    <a href="https://plos.org/resources/editor-center" >Editor Center</a>
  </li>

      <li>
    <a href="/plosone/s/resources-for-editors" >Resources for Editors</a>
  </li>

      <li>
    <a href="/plosone/s/reviewer-guidelines" >Guidelines for Reviewers</a>
  </li>

      <li>
    <a href="/plosone/s/accepted-manuscripts" >Accepted Manuscripts</a>
  </li>

      <li>
    <a href="/plosone/s/comments" >Comments</a>
  </li>

    </ul>

  </li>
        </ul>
          <div class="calloutcontainer">



  <h3 class="callout-headline">Submit Your Manuscript</h3>

  <div class="action-contain">
  <p class="callout-content">
  Discover a faster, simpler path to publishing in a high-quality journal. <em>PLOS ONE</em> promises fair, rigorous peer review,
  broad scope, and wide readership – a perfect fit for your research every time.
  </p>

  <p class="button-contain special">
    <a class="button button-default" href="/plosone/static/publish">
     Learn More
    </a>
    <a class="button-link" href="https://www.editorialmanager.com/pone/default.asp">
      Submit Now
    </a>
  </p>
  </div>  <!-- opens in siteMenuCalloutDescription -->


          </div>
      </div>
    </li>



  <li class="menu-section-header has-dropdown " id="about">
    <span class="menu-section-header-title">  About </span>

    <ul class="menu-section dropdown "
        id="about-dropdown-list">
      <li>
    <a href="/plosone/static/publish" >Why Publish with PLOS ONE</a>
  </li>

      <li>
    <a href="/plosone/s/journal-information" >Journal Information</a>
  </li>

      <li>
    <a href="/plosone/s/staff-editors" >Staff Editors</a>
  </li>

      <li>
    <a href="/plosone/static/editorial-board" >Editorial Board</a>
  </li>

      <li>
    <a href="/plosone/s/section-editors" >Section Editors</a>
  </li>

      <li>
    <a href="/plosone/s/advisory-groups" >Advisory Groups</a>
  </li>

      <li>
    <a href="/plosone/s/find-and-read-articles" >Find and Read Articles</a>
  </li>

      <li>
    <a href="/plosone/s/publishing-information" >Publishing Information</a>
  </li>

      <li>
    <a href="https://plos.org/publication-fees" >Publication Fees</a>
  </li>

      <li>
    <a href="https://plos.org/press-and-media" >Press and Media</a>
  </li>

      <li>
    <a href="/plosone/s/contact" >Contact</a>
  </li>

    </ul>

  </li>

  <li data-js-tooltip-hover="trigger" class="subject-area menu-section-header">
  Browse
  </li>

<script src="/resource/js/vendor/jquery.hoverIntent.js" type="text/javascript"></script>
<script src="/resource/js/components/menu_drop.js" type="text/javascript"></script>
<script src="/resource/js/components/hover_delay.js" type="text/javascript"></script>
      <li id="navsearch" class="head-search">


    <form name="searchForm" action="/plosone/search" method="get">
      <fieldset>
        <legend>Search</legend>
        <label for="search">Search</label>
        <div class="search-contain">
          <input id="search" type="text" name="q" placeholder="SEARCH" required/>
          <button id="headerSearchButton" type="submit" aria-label="Submit search">
            <i title="Submit search" class="search-icon"></i>
          </button>
        </div>
      </fieldset>
      <input type="hidden" name="filterJournals" value="PLoSONE"/>
    </form>

    <a id="advSearch"
       href="/plosone/search">
      advanced search
    </a>




<script src="/resource/js/components/placeholder_style.js" type="text/javascript"></script>
      </li>

      </ul>     
      </section>  
    </nav>
  </div>

</header>
<section id="taxonomyContainer">

<script src="/resource/js/taxonomy-browser.js" type="text/javascript"></script>
<div id="taxonomy-browser" class="areas" data-search-url="/plosone/browse">
  <div class="wrapper">
    <div class="taxonomy-header">
      Browse Subject Areas
      <div id="subjInfo">?</div>
      <div id="subjInfoText">
        <p>Click through the PLOS taxonomy to find articles in your field.</p>
        <p>For more information about PLOS Subject Areas, click
          <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.
        </p>
      </div>
    </div>
    <div class="levels">
      <div class="levels-container cf">
        <div class="levels-position"></div>
      </div>
      <a href="#" class="prev"></a>
      <a href="#" class="next active"></a>
    </div>
  </div>
  <div class="taxonomy-browser-border-bottom"></div>
</div>
</section>
<main> <div class="set-grid">

<header class="title-block">



<script src="/resource/js/components/signposts.js" type="text/javascript"></script>

<ul id="almSignposts" class="signposts">
  <li id="loadingMetrics">
    <p>Loading metrics</p>
  </li>
</ul>

<script type="text/template" id="signpostsGeneralErrorTemplate">
  <li id="metricsError">Article metrics are unavailable at this time. Please try again later.</li>
</script>

<script type="text/template" id="signpostsNewArticleErrorTemplate">
  <li></li><li></li><li id="tooSoon">Article metrics are unavailable for recently published articles.</li>
</script>

<script type="text/template" id="signpostsTemplate">
    <li id="almSaves">
      <%= s.numberFormat(saveCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#savedHeader">Save</a>
        <p class="saves-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#savedHeader">Total Mendeley and Citeulike bookmarks.</a></p>
      </div>
    </li>

    <li id="almCitations">
      <%= s.numberFormat(citationCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#citedHeader">Citation</a>
        <p class="citations-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#citedHeader">Paper's citation count computed by Dimensions.</a></p>
      </div>
    </li>

    <li id="almViews">
      <%= s.numberFormat(viewCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#viewedHeader">View</a>
        <p class="views-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#viewedHeader">PLOS views and downloads.</a></p>
      </div>
    </li>

    <li id="almShares">
      <%= s.numberFormat(shareCount, 0) %>
      <div class="tools" data-js-tooltip-hover="trigger">
        <a class="metric-term" href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#discussedHeader">Share</a>
        <p class="shares-tip" data-js-tooltip-hover="target"><a href="/plosone/article/metrics?id=10.1371/journal.pone.0096343#discussedHeader">Sum of Facebook, Twitter, Reddit and Wikipedia activity.</a></p>
      </div>
    </li>
</script>

    <div class="article-meta">

<div class="classifications">
  <p class="license-short" id="licenseShort">Open Access</p>
  <p class="peer-reviewed" id="peerReviewed">Peer-reviewed</p>

<div class="article-type" >
  <p class="type-article" id="artType">Research Article</p>
</div>


</div>


    </div>
    <div class="article-title-etc">



<div class="title-authors">
  <h1 id="artTitle"><?xml version="1.0" encoding="UTF-8"?>Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells</h1>

<ul class="author-list clearfix"  data-js-tooltip="tooltip_container" id="author-list">



<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="0" class="author-name" >
Ambrish Kumar,</a>    <div id="author-meta-0" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-0"><span class="type">Affiliation</span>
    Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose0"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="1" class="author-name" >
Daping Fan,</a>    <div id="author-meta-1" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-1"><span class="type">Affiliation</span>
    Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose1"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="2" class="author-name" >
Donald J. DiPette,</a>    <div id="author-meta-2" class="author-info" data-js-tooltip="tooltip_target">

  
  
  <p id="authAffiliations-2"><span class="type">Affiliation</span>
    Department of Internal Medicine, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose2"> &#x02A2F; </a>
    </div>
</li>

<li
  data-js-tooltip="tooltip_trigger"
  
>
   <a  data-author-id="3" class="author-name" >
Ugra S. Singh <span class="email">  </span></a>    <div id="author-meta-3" class="author-info" data-js-tooltip="tooltip_target">

  
  <p id="authCorresponding-3"> <span class="email">* E-mail:</span> <a href="mailto:Ugra.Singh@uscmed.sc.edu">Ugra.Singh@uscmed.sc.edu</a></p>
  <p id="authAffiliations-3"><span class="type">Affiliation</span>
    Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America
  </p>

      <a data-js-tooltip="tooltip_close" class="close" id="tooltipClose3"> &#x02A2F; </a>
    </div>
</li>

</ul>
<script src="/resource/js/components/tooltip.js" type="text/javascript"></script>

</div>


<div id="floatTitleTop" data-js-floater="title_author" class="float-title">
  <div class="set-grid">
    <div class="float-title-inner">
      <h1><?xml version="1.0" encoding="UTF-8"?>Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells</h1>

<ul id="floatAuthorList" data-js-floater="floated_authors">

  <li data-float-index="1">Ambrish Kumar,&nbsp;

  </li>
  <li data-float-index="2">Daping Fan,&nbsp;

  </li>
  <li data-float-index="3">Donald J. DiPette,&nbsp;

  </li>
  <li data-float-index="4">Ugra S. Singh

  </li>

</ul>



    </div>
    <div class="logo-close" id="titleTopCloser">
      <img src="/resource/img/logo-plos.png" style="height: 2em" alt="PLOS" />
      <div class="close-floater" title="close">x</div>
    </div>
  </div>
</div>

      <ul class="date-doi">
        <li id="artPubDate">Published: May 1, 2014</li>
        <li id="artDoi">
<a   href="https://doi.org/10.1371/journal.pone.0096343">https://doi.org/10.1371/journal.pone.0096343</a>
        </li>
        <li class="flex-spacer"></li>
      </ul>

    </div>
  <div>

  </div>
</header>
  <section class="article-body">



<ul class="article-tabs">

          <li class="tab-title active" id="tabArticle">
            <a href="/plosone/article?id=10.1371/journal.pone.0096343" class="article-tab-1">Article</a>
        </li>


              <li class="tab-title " id="tabAuthors">
            <a href="/plosone/article/authors?id=10.1371/journal.pone.0096343" class="article-tab-2">Authors</a>
        </li>


          <li class="tab-title " id="tabMetrics">
            <a href="/plosone/article/metrics?id=10.1371/journal.pone.0096343" class="article-tab-3">Metrics</a>
        </li>


          <li class="tab-title " id="tabComments">
            <a href="/plosone/article/comments?id=10.1371/journal.pone.0096343" class="article-tab-4">Comments</a>
        </li>

  <li class="tab-title" id="tabRelated">
    <a class="article-tab-5" id="tabRelated-link">Media Coverage</a> 
    <script>$(document).ready(function() { $.getMediaLink("10.1371/journal.pone.0096343").then(function (url) { $("#tabRelated-link").attr("href", url) } ) })</script>
  </li>
</ul>

    <div class="article-container">


<div id="nav-article">
  <ul class="nav-secondary">

    <li class="nav-comments" id="nav-comments">
      <a href="article/comments?id=10.1371/journal.pone.0096343">Reader Comments</a>
    </li>

    <li id="nav-figures"><a href="#" data-doi="10.1371/journal.pone.0096343">Figures</a></li>
  </ul>
</div>
<script src="/resource/js/components/scroll.js" type="text/javascript"></script>
<script src="/resource/js/components/nav_builder.js" type="text/javascript"></script>
<script src="/resource/js/components/floating_nav.js" type="text/javascript"></script>

<div id="figure-lightbox-container"></div>

<script id="figure-lightbox-template" type="text/template">
  <div id="figure-lightbox" class="reveal-modal full" data-reveal aria-hidden="true"
       role="dialog">
    <div class="lb-header">
      <h1 id="lb-title"><%= articleTitle %></h1>

      <div id="lb-authors">
            <span>Ambrish Kumar</span>
            <span>Daping Fan</span>
            <span>Donald J. DiPette</span>
            <span>Ugra S. Singh</span>
      </div>

      <div class="lb-close" title="close">&nbsp;</div>
    </div>
    <div class="img-container">
      <div class="loader"> <i class="fa-spinner"></i> </div>
      <img class="main-lightbox-image" src=""/>
      <aside id="figures-list">
        <% figureList.each(function (ix, figure) { %>
        <div class="change-img" data-doi="<%= figure.getAttribute('data-doi') %>">
          <img class="aside-figure" src="/plosone/article/figure/image?size=inline&id=<%= figure.getAttribute('data-doi') %>" />
        </div>
        <% }) %>
        <div class="dummy-figure">
        </div>
      </aside>
    </div>
    <div id="lightbox-footer">

      <div id="btns-container" class="lightbox-row <% if(figureList.length <= 1) { print('one-figure-only') } %>">
        <div class="fig-btns-container reset-zoom-wrapper left">
          <span class="fig-btn reset-zoom-btn">Reset zoom</span>
        </div>
        <div class="zoom-slider-container">
          <div class="range-slider-container">
            <span id="lb-zoom-min"></span>
            <div class="range-slider round" data-slider data-options="start: 20; end: 200; initial: 20;">
              <span class="range-slider-handle" role="slider" tabindex="0"></span>
              <span class="range-slider-active-segment"></span>
              <input type="hidden">
            </div>
            <span id="lb-zoom-max"></span>
          </div>
        </div>
        <% if(figureList.length > 1) { %>
        <div class="fig-btns-container">
          <span class="fig-btn all-fig-btn"><i class="icon icon-all"></i> All Figures</span>
          <span class="fig-btn next-fig-btn"><i class="icon icon-next"></i> Next</span>
          <span class="fig-btn prev-fig-btn"><i class="icon icon-prev"></i> Previous</span>
        </div>
        <% } %>
      </div>
      <div id="image-context">
      </div>
    </div>
  </div>
</script>

<script id="image-context-template" type="text/template">
  <div class="footer-text">
    <div id="figure-description-wrapper">
      <div id="view-more-wrapper" style="<% descriptionExpanded? print('display:none;') : '' %>">
        <span id="figure-title"><%= title %></span>
        <p id="figure-description">
          <%= description %>&nbsp;&nbsp;
        </p>
        <span id="view-more">show more<i class="icon-arrow-right"></i></span>

      </div>
      <div id="view-less-wrapper" style="<% descriptionExpanded? print('display:inline-block;') : '' %>" >
        <span id="figure-title"><%= title %></span>
        <p id="full-figure-description">
          <%= description %>&nbsp;&nbsp;
          <span id="view-less">show less<i class="icon-arrow-left"></i></span>
        </p>
      </div>
    </div>
  </div>
  <div id="show-context-container">
    <a class="btn show-context" href="<%= showInContext(strippedDoi) %>">Show in Context</a>
  </div>
  <div id="download-buttons">
    <h3>Download:</h3>
    <div class="item">
      <a href="/plosone/article/figure/image?size=original&download=&id=<%= doi %>" title="original image">
        <span class="download-btn">TIFF</span>
      </a>
      <span class="file-size"><%= fileSizes.original %></span>
    </div>
    <div class="item">
      <a href="/plosone/article/figure/image?size=large&download=&id=<%= doi %>" title="large image">
        <span class="download-btn">PNG</span>
      </a>
      <span class="file-size"><%= fileSizes.large %></span>
    </div>
    <div class="item">
      <a href="/plosone/article/figure/powerpoint?id=<%= doi %>" title="PowerPoint slide">
        <span class="download-btn">PPT</span>
      </a>
    </div>

  </div>
</script>
      <div class="article-content">




  <div class="amendment amendment-correction toc-section">
  <a data-toc="amendment-0" title="Correction" id="amendment-0" name="amendment-0"></a>

  <h2>Correction</h2>
    <div class="amendment-citation">
      <p>
          <span class="amendment-date">
            6 Jul 2016:
          </span>


Kumar&nbsp;A,
Fan&nbsp;D,
DiPette&nbsp;DJ,
Singh&nbsp;US


  (2016)

    <?xml version="1.0" encoding="UTF-8"?>Correction: Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells.

PLOS ONE  11(7): e0159082.

<a   href="https://doi.org/10.1371/journal.pone.0159082">https://doi.org/10.1371/journal.pone.0159082</a>


            <span class="link-separator"> </span>
            <a href="/plosone/article?id=10.1371/journal.pone.0159082" class="amendment-link">
              View 
  correction

            </a>
      </p>
    </div>
  </div>


<div id="figure-carousel-section">
  <h2>Figures</h2>

  <div id="figure-carousel">

    <div class="carousel-wrapper">
      <div class="slider">

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0096343.g001">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g001"
                     loading="lazy"
                     alt="Figure 1"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0096343.g002">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g002"
                     loading="lazy"
                     alt="Figure 2"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0096343.g003">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g003"
                     loading="lazy"
                     alt="Figure 3"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0096343.g004">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g004"
                     loading="lazy"
                     alt="Figure 4"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0096343.g005">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g005"
                     loading="lazy"
                     alt="Figure 5"
                />

            </div>

          <div class="carousel-item lightbox-figure" data-doi="10.1371/journal.pone.0096343.g006">

                <img src="/plosone/article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g006"
                     loading="lazy"
                     alt="Figure 6"
                />

            </div>
      </div>
    </div>

    <div class="carousel-control">
      <span class="button previous"></span>
      <span class="button next"></span>
    </div>
    <div class="carousel-page-buttons">

    </div>
  </div>
</div>
<script src="/resource/js/vendor/jquery.touchswipe.js" type="text/javascript"></script>
<script src="/resource/js/components/figure_carousel.js" type="text/javascript"></script>
<script src="/resource/js/vendor/jquery.dotdotdot.js" type="text/javascript"></script>


        <div class="article-text" id="artText">
          



<div xmlns:plos="http://plos.org" class="abstract toc-section abstract-type-"><a id="abstract0" name="abstract0" data-toc="abstract0" class="link-target" title="Abstract"></a><h2>Abstract</h2><div class="abstract-content"><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1" class="link-target"></a><p>Neuroblastoma is one of the most common solid tumors and accounts for ∼15% of all the cancer related deaths in the children. Despite the standard therapy for advanced disease including chemotherapy, surgery, and radiation, the mortality rate remains high for these patients. Hence, novel therapeutic agents are desperately needed. Here we examined the anticancer activity of a novel plant-derived compound, sparstolonin B (SsnB; 8,5′-dihydroxy-4-phenyl-5,2′-oxidoisocoumarin) using neuroblastoma cell lines of different genetics. SsnB was recently isolated from an aquatic Chinese herb, <em>Sparganium stoloniferum</em>, and tubers of this herb have been used in traditional Chinese medicine for the treatment of several inflammatory diseases and cancers. Our cell viability and morphological analysis indicated that SsnB at 10 µM concentration significantly inhibited the growth of both N-myc amplified (SK-N-BE(2), NGP, and IMR-32 cells) and N-myc nonamplified (SH-SY5Y and SKNF-1 cells) neuroblastoma cells. The flow cytometric analyses suggested that SsnB arrests the cell cycle progression at G2-M phase in all neuroblastoma cell lines tested. Exposure of SsnB inhibited the compact spheroid formation and reduced the tumorigenicity of SH-SY5Y cells and SK-N-BE(2) cells in <em>in vitro</em> 3-D cell culture assays (anchorage-independent colony formation assay and hanging drop assay). SsnB lowers the cellular level of glutathione (GSH), increases generation of reactive oxygen species and activates the cleavage of caspase-3 whereas co-incubation of a GSH precursor, N-acetylcysteine, along with SsnB attenuates the inhibitory effects of SsnB and increases the neuroblastoma cell viability. Our results for the first time demonstrate that SsnB possesses anticancer activity indicating that SsnB-induced reactive oxygen species generation promotes apoptotic cell death in neuroblastoma cells of different genetic background. Thus these data suggest that SsnB can be a promising drug candidate in neuroblastoma therapy.</p>
</div></div>


<div xmlns:plos="http://plos.org" class="articleinfo"><p><strong>Citation: </strong>Kumar A, Fan D, DiPette DJ, Singh US (2014) Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells. PLoS ONE 9(5):
           e96343.
        
        https://doi.org/10.1371/journal.pone.0096343</p><p><strong>Editor: </strong>Pranela Rameshwar, Rutgers - New Jersey Medical School, United States of America</p><p><strong>Received: </strong>January 9, 2014; <strong>Accepted: </strong>April 5, 2014; <strong>Published: </strong> May 1, 2014</p><p><strong>Copyright: </strong> © 2014 Kumar et al. This is an open-access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This research was supported by National Institutes of Health Grants R21AA016121 to USS, R21AT006767 and R01HL116626 to DF, and Health Sciences Distinguished Professorship financial support to DJD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p><p><strong>Competing interests: </strong> The authors have declared that no competing interests exist.</p></div>





<div xmlns:plos="http://plos.org" id="section1" class="section toc-section"><a id="s1" name="s1" data-toc="s1" class="link-target" title="Introduction"></a><h2>Introduction</h2><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1" class="link-target"></a><p>Sparstolonin B (SsnB) is a novel plant derived active compound recently isolated from the tubers of an aquatic herb, <em>Sparganium stoloniferum</em> <a href="#pone.0096343-Liang1" class="ref-tip">[1]</a>. <em>In vivo</em> and <em>in vitro</em> studies revealed its anti-inflammatory <a href="#pone.0096343-Liang1" class="ref-tip">[1]</a>, <a href="#pone.0096343-Liang2" class="ref-tip">[2]</a> and anti-angiogenic <a href="#pone.0096343-Bateman1" class="ref-tip">[3]</a> properties. SsnB acts as an antagonist to Toll-like Receptors 2 and 4 (TLR2 and TLR4), and exhibits anti-inflammatory property by selectively inhibiting TLR2 and TLR4-triggered inflammatory response in mouse and human macrophages <a href="#pone.0096343-Liang1" class="ref-tip">[1]</a>, <a href="#pone.0096343-Liang2" class="ref-tip">[2]</a>. In traditional Chinese medicine (TCM), the tubers of this herb have been used for the treatment of several inflammatory diseases, and the crude extract prepared form this herb has anti-spasmodic and anti-tumor properties <a href="#pone.0096343-Li1" class="ref-tip">[4]</a>–<a href="#pone.0096343-Lee1" class="ref-tip">[6]</a>. As revealed by NMR and X-ray crystallography, SsnB (8,5′-dyhydroxy-4-phenyl-5,2′-oxidoisocoumarin) is a polyphenol with structural similarities to isocoumarins and xanthone. Isocoumarins and xanthone family of compounds are well known for their anti-inflammatory and anti-tumor properties <a href="#pone.0096343-Riveiro1" class="ref-tip">[7]</a>–<a href="#pone.0096343-Na1" class="ref-tip">[10]</a>. Due to the structural similarities of SsnB with isocoumarins and xanthone, we decided to examine the anticancerous properties of SsnB.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2" class="link-target"></a><p>Neuroblastoma is a malignant pediatric cancer of the postganglionic sympathetic nervous system and derived from the neural crest cells during embryonic development. Initially it develops in the adrenal gland and metastasizes to liver, bone, bone marrow, lymph nodes, neck and chest. It is the most common cancer in babies younger than one and second most common tumor in children <a href="#pone.0096343-Cheung1" class="ref-tip">[11]</a>, <a href="#pone.0096343-Davidoff1" class="ref-tip">[12]</a>. It accounts for 7% of all childhood cancers (Cancer Facts &amp; Figures 2013. Atlanta, GA: American Cancer Society, 2013), and is responsible for 15% of all cancer deaths in children younger than 15 years. About 30%–50% of children with high-risk neuroblastoma experience long-term survival.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3" class="link-target"></a><p>Neuroblastoma tumor comprises of various heterogeneous population of cells which differ at morphological, biochemical and genetic levels <a href="#pone.0096343-Ciccarone1" class="ref-tip">[13]</a>–<a href="#pone.0096343-Kamijo1" class="ref-tip">[15]</a>. Genomic amplification of N-myc gene, rearrangement or deletion of distal region of the chromosome 1 (1p31-arm) <a href="#pone.0096343-Brodeur1" class="ref-tip">[16]</a>, <a href="#pone.0096343-Gilbert1" class="ref-tip">[17]</a> or alterations in chromosomes 11, 14 and 17 <a href="#pone.0096343-Gilbert2" class="ref-tip">[18]</a>, <a href="#pone.0096343-Srivatsan1" class="ref-tip">[19]</a> are most common cytogenetic features identified in low to advance stages of neuroblastomas. Mutations in tumor suppresser genes, i.e., p53, retinoblastoma, RET, p16, p18 or p27 have been reported to promote tumorigenesis <a href="#pone.0096343-Imamura1" class="ref-tip">[20]</a>–<a href="#pone.0096343-Hofstra1" class="ref-tip">[22]</a>. These karyotype and cytogenetic alterations render tumors resistant to available chemotherapies <a href="#pone.0096343-Morgenstern1" class="ref-tip">[23]</a>. For example, retinoic acid induces neuronal differentiation in neuroblastoma cells <a href="#pone.0096343-Sidell1" class="ref-tip">[24]</a>, <a href="#pone.0096343-Singh1" class="ref-tip">[25]</a> and commonly used as in residual therapy. However, neuroblastoma cells with N-myc amplified oncogene do not respond to retinoic acid <a href="#pone.0096343-Thiele1" class="ref-tip">[26]</a>, <a href="#pone.0096343-Joshi1" class="ref-tip">[27]</a>. Therefore, it is crucial to find new therapeutic agents that can exhibit anti-proliferative effects on neuroblastoma cells irrespective of their genetic abnormalities.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4" class="link-target"></a><p>In the present study, for the first time we have reported the anticancer activity of SsnB and have demonstrated that SsnB inhibits the growth of human neuroblastoma cells of different genetic background by arresting cell cycle progression and by inducing apoptotic cell death through generation of reactive oxygen species.</p>
</div>

<div xmlns:plos="http://plos.org" id="section2" class="section toc-section"><a id="s2" name="s2" data-toc="s2" class="link-target" title="Materials and Methods"></a><h2>Materials and Methods</h2>
<div id="section1" class="section toc-section"><a id="s2a" name="s2a" class="link-target" title="Human Neuroblastoma Cell Culture and SsnB Treatments"></a>
<h3>Human Neuroblastoma Cell Culture and SsnB Treatments</h3>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1" class="link-target"></a><p>Human neuroblastoma cell lines (SH-SY5Y, IMR-32, SK-N-BE(2) and SKNF-1 cells) were obtained from The American Type Culture Collection (ATCC; Manassas, VA), and NGP cells were kind gift from Garrett M. Brodeur (The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania) <a href="#pone.0096343-Azar1" class="ref-tip">[28]</a>. All cell lines were maintained in complete Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Atlanta Biologicals, Lawrenceville, GA) and 1× antibiotic-antimycotic solution (containing 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin B), and grown at 37°C in a humidified incubator with 5% CO<sub>2</sub>. Stock solution of SsnB was prepared in dimethyl sulfoxide (DMSO). Cells treated with different concentrations of SsnB in DMEM with 10% FBS were grown for subsequent days. Cells treated with equal volume of DMSO were used as control.</p>
</div>

<div id="section2" class="section toc-section"><a id="s2b" name="s2b" class="link-target" title="Cell Viability Assay"></a>
<h3>Cell Viability Assay</h3>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1" class="link-target"></a><p>The viability of SsnB-treated cells was determined by MTT assay following manufacturer’s instructions (Roche diagnostics corporation, Indianapolis, IN). Briefly, cells (1×10<sup>4</sup> cells/well) grown in 96-well cell culture plate were incubated with SsnB in 100 µl of complete culture medium with 10% FBS. After treatments, cells were incubated with 10 µl of MTT reagent for 4 h and then incubated overnight in solubilization buffer (100 µl) at 37°C. Absorbance of the formazan product was read at 575 nm in spectramax spectrophotometer (Molecular Devices, Sunnyvale, CA). A reference wavelength of 690 nm was used to detect background. The measured absorption directly correlates with the number of viable cells in culture. The experiments were performed in triplicates and repeated at least three times.</p>
</div>

<div id="section3" class="section toc-section"><a id="s2c" name="s2c" class="link-target" title="Cell Cycle Analyses by Flow Cytometry"></a>
<h3>Cell Cycle Analyses by Flow Cytometry</h3>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1" class="link-target"></a><p>The cell cycle progression was determined by flow cytometer analysis <a href="#pone.0096343-Pozarowski1" class="ref-tip">[29]</a>. Neuroblastoma cells were treated with SsnB or DMSO in DMEM with 10% FBS. Cells were collected after trypsinization with trypsin-EDTA solution (Atlanta Biologicals) and washed with 1× phosphate buffered saline (PBS). Approximately 1×10<sup>6</sup> cells were suspended in 300 µl of ice-cold 1× PBS, fixed by adding 700 µl of chilled absolute ethanol (to make final ethanol concentration 70%) drop wise and incubated for overnight at −20°C. Cells were pelleted at 1000× rpm for 5 min at 4°C, washed with 1× PBS for 3 times and stained with propidium iodide (Sigma-Aldrich, St. Louis, MO) by adding 1 ml of propidium iodide staining solution (containing 20 µg/ml propidium iodide and 10 µg/ml DNase-free RNase A in 0.1% Triton X-100/PBS) for 1 h on ice in dark. Samples were subjected to fluorescence-activated cell sorting analyses utilizing Beckman Coulter flow cytometer (Beckman Coulter, Indianapolis, IN). A minimum of 10,000 events were analyzed in each experiment.</p>
</div>

<div id="section4" class="section toc-section"><a id="s2d" name="s2d" class="link-target" title="Immunofluorescence Microscopy"></a>
<h3>Immunofluorescence Microscopy</h3>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1" class="link-target"></a><p>For immunofluorescence staining, cells grown in Lab-TekII chamber slides (Fisher Scientific, Pittsburgh, PA) were treated with SsnB compound in complete culture medium. After treatments, cells were washed with 1× PBS, fixed with 4% paraformaldehyde/PBS for 20 min, and permeabilized with 0.2% Triton X-100/PBS for 10 min at room temperature. Cells were washed with 1× PBS for 3 times and blocked with 5% immunoglobulin (IgG) free-bovine serum albumin (BSA; Jackson ImmunoResearch Laboratories, West Grove, PA) in 1× PBS for overnight at 4°C. Cells were incubated with antibody raised against active form of caspase-3 (Cell Signaling Technology, Danvers, MA) diluted in 2.5% BSA/PBS for overnight at 4°C. Primary antibodies were detected with secondary antibodies conjugated with fluorescein isothiocyanate (FITC; Santa Cruz Biotechnology, Dallas, TX) for 2 h at room temperature. After washing with 1× PBS, cells were mounted with antifade Vectashield mounting media (Vector Laboratories, Burlingame, CA), and signals were visualized under Nikon-E600 fluorescence microscope. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI; Sigma).</p>
</div>

<div id="section5" class="section toc-section"><a id="s2e" name="s2e" class="link-target" title="Total Cell Protein Isolation and Western Blot Analyses"></a>
<h3>Total Cell Protein Isolation and Western Blot Analyses</h3>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1" class="link-target"></a><p>After treatment with SsnB, cells were collected, washed with 1× PBS, and lysed with 1× cell lysis buffer (Cell Signaling Technology, Danvers, MA) containing phenylmethylsulfonyl fluoride (PMSF) and protease inhibitors (aprotinin and leupeptin) for 30 min on ice, and centrifuged at 12000× rpm for 10 min at 4°C. Supernatant (total cell protein) was collected and stored at −80°C. Protein concentration was determined by bicinchoninic acid method using BCA protein assay kit (Pierce/ThermoScientific, Waltham, MA). Equal amount of proteins were diluted with 5 x Laemmli samples loading buffer and boiled for five minutes. The proteins were subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and analyzed by Western blots <a href="#pone.0096343-Kumar1" class="ref-tip">[30]</a>. Briefly, after electrophoresis, proteins were transferred on polyvinylidene difluoride (PVDF) membrane at 100 volt for 3 h in cold room. Membrane was blocked with 5% non-fat dry milk/TBST (20 mM Tris-Cl, pH 7.4; 150 mM NaCl with 0.1% Tween-20) for 4 h at room temperature followed by incubation in primary antibodies diluted in 2.5% non-fat dry milk/TBST for overnight at 4°C. After washing with TBST, membrane was incubated with secondary antibodies (horseradish peroxidase-conjugated goat anti-rabbit or goat anti-mouse IgG; Santa Cruz Biotechnology, Dallas, TX) diluted in 2.5% non-fat dry milk/TBST for 3 h at room temperature. Signals were detected by chemiluminiscence detection kit (Pierce/Thermo Fisher Scientific, Rockford, IL). Primary antibodies used were cleaved caspase-3 and β-actin (Cell Signaling Technology), N-myc and p53 (Santa Cruz Biotechnology).</p>
</div>

<div id="section6" class="section toc-section"><a id="s2f" name="s2f" class="link-target" title="Detection of Reactive Oxygen Species Generation"></a>
<h3>Detection of Reactive Oxygen Species Generation</h3>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1" class="link-target"></a><p>The production of reactive oxygen species (ROS) in SsnB-treated neuroblastoma cells was detected by a cell-permeable fluorescence probe H<sub>2</sub>DCFDA (carboxy-2′,7′-dichlorodihydrofluorescein diacetate) according to the manufacturer’s instructions (Invitrogen, Carlsbad, CA) <a href="#pone.0096343-Karlsson1" class="ref-tip">[31]</a>. Briefly, neuroblastoma cells were cultured in DMEM with 10% FBS in Lab-TekII chamber slides (Fisher Scientific, Pittsburg, PA) and treated with SsnB for 2 days (SH-SY5Y and IMR-32 cells), 3 days (NGP cell) or 4 days (SKNF-1 and SK-N-BE(2) cells). After treatments, cells were washed with Hank’s buffered salt solution (HBSS; Thermo Scientific, Waltham, MA) and incubated with 25 µM of carboxy-H<sub>2</sub>DCFDA dye for 30 min at 37°C in dark. Nuclei were counterstained with DAPI. Cells were washed three times with HBSS, mounted with Vectashield mounting medium (Vector Laboratories), and immediately examined under Nikon-E600 fluorescence microscopy equipped with fluorescein isothiocyanate (FITC) filter <a href="#pone.0096343-Kumar2" class="ref-tip">[32]</a>. Oxidation of H<sub>2</sub>DCFDA probe occurs almost exclusively in the cytosol, and generates a fluorescence that is proportional to ROS generation in that cell. As a negative control, cells without H<sub>2</sub>DCFDA dye were used to detect autofluorescence. The fluorometric analysis to detect generation of ROS was performed as described previously <a href="#pone.0096343-Zhang1" class="ref-tip">[33]</a>. Briefly, after treatments with SsnB as mentioned above, cells were labelled with carboxy-H<sub>2</sub>DCFDA dye (25 µM) for 30 min at 37°C. Cells were trypsinized, washed, and re-suspended in PBS and fluorescence intensity was monitored at excitation wavelength 485 nm and emission wavelength 530 nm with a spectramax spectrophotometer (Molecular Devices, Sunnyvale, CA).</p>
</div>

<div id="section7" class="section toc-section"><a id="s2g" name="s2g" class="link-target" title="Colony Formation Assay"></a>
<h3>Colony Formation Assay</h3>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1" class="link-target"></a><p>A two layer soft agarose assay system was used in these studies with some modifications <a href="#pone.0096343-BaumannKubetzko1" class="ref-tip">[34]</a>. Approximately 1×10<sup>4</sup> cells were suspended in 0.35% agarose in DMEM with 10% FBS, and were gently laid on the bottom agarose layer containing 0.8% agarose with DMEM+10% FBS in 35 mm<sup>2</sup> cell culture dishes. Once solidified, the dishes were incubated at 37°C in a humidified chamber with 5% CO<sub>2</sub>. Next day, 500 µl of complete cell culture medium with respective concentrations of SsnB was added, and cells were allowed to grow for 45 days in an incubator chamber. Fresh medium with respective concentrations of SsnB was added to the dishes in every 5 days. Cells treated with equal volume of DMSO were used as control. At the end of experiments, cells were stained with 0.1% crystal violet and cell colonies (more than 15 cells per colony) were counted under the light microscope.</p>
</div>

<div id="section8" class="section toc-section"><a id="s2h" name="s2h" class="link-target" title="Hanging-drop Assay for Spheroid Formation"></a>
<h3>Hanging-drop Assay for Spheroid Formation</h3>
<a id="article1.body1.sec2.sec8.p1" name="article1.body1.sec2.sec8.p1" class="link-target"></a><p>3-D <em>in vitro</em> hanging drop assay was carried out to detect the SsnB effect in neuroblastoma spheroid formation <a href="#pone.0096343-Sodek1" class="ref-tip">[35]</a>. Neuroblastoma cells were prepared as single cell suspension in complete culture medium (DMEM+10% FBS) without or with SsnB (1 and 10 µM). Twenty microliter drop of each prepared cell suspension containing 20,000 cells/drop were pipetted into the inner side of the lid of a 60 mm diameter tissue culture dish. The lid was gently inverted and placed on top of the culture dish filled with 5 ml of sterile 1× PBS to humidify the culture chamber. The drops were incubated under tissue culture conditions (at 37°C and 5% CO<sub>2</sub>) allowing the cells to form aggregate at the base of the droplet. The cells in each droplet were photographed using Olympus SZX2 stereo microscope (Olympus America Inc., Center Valley, PA).</p>
</div>

<div id="section9" class="section toc-section"><a id="s2i" name="s2i" class="link-target" title="Measurement of Glutathione (GSH) Level"></a>
<h3>Measurement of Glutathione (GSH) Level</h3>
<a id="article1.body1.sec2.sec9.p1" name="article1.body1.sec2.sec9.p1" class="link-target"></a><p>Cells treated with SsnB or DMSO were washed and re-suspended in PBS and the intracellular GSH level was measured by luminescence based GSH-Glo glutathione assay kit (Promega, Madison, WI) following manufacturer’s protocol. The luminescence was monitored in a luminometer (Promega Biosystems, Sunnyvale, CA).</p>
</div>

<div id="section10" class="section toc-section"><a id="s2j" name="s2j" class="link-target" title="Data Analysis"></a>
<h3>Data Analysis</h3>
<a id="article1.body1.sec2.sec10.p1" name="article1.body1.sec2.sec10.p1" class="link-target"></a><p>Data are presented as the mean and standard deviation (S.D.) of at least three independent experiments. Comparisons were made among the groups using one-way ANOVA followed by Tukey-Kramer ad hoc test (GraphPad software, La Jolla, CA). A <em>p</em>-value&lt;0.05 was considered significant.</p>
</div>
</div>

<div xmlns:plos="http://plos.org" id="section3" class="section toc-section"><a id="s3" name="s3" data-toc="s3" class="link-target" title="Results"></a><h2>Results</h2>
<div id="section1" class="section toc-section"><a id="s3a" name="s3a" class="link-target" title="SsnB Inhibits the Survival of Neuroblastoma Cells"></a>
<h3>SsnB Inhibits the Survival of Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1" class="link-target"></a><p>To test the inhibitory effects of SsnB on neuroblastoma cell survival, we treated human neuroblastoma cell lines of different genetic background (SH-SY5Y, SKNF-1, NGP, IMR-32 and SK-N-BE(2) cells) with 1 µM, 5 µM, 10 µM or 20 µM concentration of SsnB under <em>in vitro</em> conditions. Following SsnB treatments, neuroblastoma cell were grown for subsequent days and were photographed under light microscope to evaluate the cell morphology. The phase contrast images as shown in <a href="#pone-0096343-g001">Figure 1A</a> demonstrated that SsnB alters the cellular appearance and promotes cell death (as evaluated by cell morphology; round and clumping of cells is indication of cell death) in all these neuroblastoma cell lines. SsnB at 10 µM and above concentrations changed the morphology (as evaluated by rounded cells and indication of cell death) of SH-SY5Y cells and IMR-32 cells (after 2 days treatment), NGP (after 3 days treatment), SKNF-1 and SK-N-BE(2) cells (after 4 days treatment) compared to control DMSO-treated cells. However, such morphological changes were not significant at 1 or 5 µM conc. of SsnB in any cell line tested.</p>
<a class="link-target" id="pone-0096343-g001" name="pone-0096343-g001"></a><div class="figure" data-doi="10.1371/journal.pone.0096343.g001"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0096343.g001" data-doi="10.1371/journal.pone.0096343" data-uri="10.1371/journal.pone.0096343.g001"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g001" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0096343.g001"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0096343.g001"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0096343.g001"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 1. </span> SsnB inhibits cell growth and viability of neuroblastoma cells.</div><p class="caption_target"><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1" class="link-target"></a><p>(A) Phase contrast images showing the morphology of neuroblastoma cells after treatments with SsnB. Neuroblastoma cells (SH-SY5Y, IMR-32, NGP, SKNF-1 and SK-N-BE(2) cells) were grown in presence of DMSO or SsnB (1, 5, 10, and 20 µM) in complete culture medium and were photographed on indicated times. (<strong>B</strong>) Bar diagrams showing the cell viability after SsnB treatment as evaluated by MTT assays. Neuroblastoma cells were treated with SsnB (1, 5, 10, and 20 µM) for 2 days (SH-SY5Y and IMR-32), 3 days (NGP) or 4 days (SKNF-1 and SK-N-BE(2) cells) and cell viability was measured by MTT assay at 575 nm. Data are represented in fold change and *<em>p</em>&lt;0.05 <em>vs</em> control. (<strong>C</strong>) SsnB arrest cell cycle at G2/M phase. Representative histograms illustrating the cell cycle progression of neuroblastoma cells in presence of SsnB. Neuroblastoma cells treated with SsnB (1 µM or 10 µM) in DMEM with 10% FBS for 2 days (SH-SY5Y and IMR-32), 3 days (NGP) or 4 days (SKNF-1 and SK-N-BE(2) cells) were labelled with propidium iodide and cell cycle stage was analyzed by flow cytometry.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0096343.g001">
              https://doi.org/10.1371/journal.pone.0096343.g001</a></p></div><a id="article1.body1.sec3.sec1.p2" name="article1.body1.sec3.sec1.p2" class="link-target"></a><p>We further carried out MTT assay to examine the effects of SsnB on viability of all the above listed neuroblastoma cells. After 2 days (SH-SY5Y and IMR-32), 3 days (NGP cells) or 4 days (SKNF-1 and SK-N-BE(2) cells) treatment with SsnB (1, 5, 10 and 20 µM), MTT cell viability assays were performed. The bar diagram in <a href="#pone-0096343-g001">Figure 1B</a> showed that SsnB inhibited, effectively and dose-dependently, the viability of all neuroblastoma cell lines tested. Compared to DMSO, SsnB at and above 10 µM concentration significantly reduced the viability of these cell lines (*<em>p</em>&lt;0.05 <em>vs</em> DMSO) and the IC<sub>20</sub> and IC<sub>50</sub> were found to be in the range of 6–8 µM and 10–12 µM, respectively. We did not observe significant difference in cell survival at SsnB at 1 µM or 5 µM concentrations compared to control DMSO-treated neuroblastoma cells (<em>p</em>&gt;0.05 <em>vs</em> DMSO). No cytotoxic response of SsnB at these concentrations (and up to ∼100 µM) was observed in various normal human cells e.g. human monocytic THP-1 cells, phorbol 12-myristate 13-acetate-differentiated THP-1 macrophages, human umbilical vein endothelial cells and human aortic smooth muscle cells as reported in reference <a href="#pone.0096343-Liang1" class="ref-tip">[1]</a>. These data demonstrate the anti-proliferative activity of SsnB on human neuroblastoma cells, and suggest that SH-SY5Y and IMR-32 cells were most sensitive, NGP cell was moderately sensitive, SKNF-1 and SK-N-BE(2) cell lines were least sensitive towards SsnB treatment. Since 50% cell viability was observed in range of 10–12 µM SsnB conc., we used 10 µM as higher conc. and 1 µM lower conc. in our further experiments.</p>
</div>

<div id="section2" class="section toc-section"><a id="s3b" name="s3b" class="link-target" title="SsnB Regulates Cell Cycle Progression in Neuroblastoma Cells"></a>
<h3>SsnB Regulates Cell Cycle Progression in Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1" class="link-target"></a><p>To test whether SsnB-induced cell growth inhibition occurs through cell cycle arrest, we analyzed cell cycle distribution by flow cytometry after DNA staining with propidium iodide. Representative histogram in <a href="#pone-0096343-g001">Figure 1C</a> showed that 2 days (SH-SY5Y, IMR-32) or 3 days (NGP cells) exposure of SsnB (10 µM) resulted in increase of G2-M phase cells when compared with DMSO-treated controls (G2/M for SH-SY5Y, SsnB 10 µM = 23.98% <em>vs</em> control = 14.33%; for IMR-32, SsnB 10 µM = 23.45% <em>vs</em> control = 19.25%; and for NGP, SsnB 10 µM = 26.98% <em>vs</em> control = 17.87%). Similarly, SsnB treatment for 4 days increases the number of SK-N-BE(2) cells and SKNF-1 cells in G2/M phase, compared to control (G2/M for SKNF-1, SsnB 10 µM  = 14.53% <em>vs</em> control = 20.91%; for SK-N-BE(2) cells, SsnB 10 µM = 27.15% <em>vs</em> control = 22.26%). The SsnB (10 µM) induced increase in G2/M fraction was accompanied by a decrease in G0/G1 phase cells. SsnB at 1 µM concentration did not affect cell cycle progression compared to DMSO-treated controls. These results indicated that the exhibited anti-proliferative effect of SsnB (10 µM) may be exerted by cell cycle arrest at G2-M transition in these neuroblastoma cell lines.</p>
</div>

<div id="section3" class="section toc-section"><a id="s3c" name="s3c" class="link-target" title="SsnB Generates Reactive Oxygen Species (ROS) in Neuroblastoma Cells"></a>
<h3>SsnB Generates Reactive Oxygen Species (ROS) in Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1" class="link-target"></a><p>Isocoumarin and coumarin derivative compounds are well known to exhibit their anti-tumor effects by reactive oxygen species-induced cell death <a href="#pone.0096343-Du1" class="ref-tip">[36]</a>, <a href="#pone.0096343-Yin1" class="ref-tip">[37]</a>. To test whether SsnB-induced cell death is resulted from increased level of reactive oxygen species (ROS), we performed H<sub>2</sub>DCFDA staining <a href="#pone.0096343-Karlsson1" class="ref-tip">[31]</a>, <a href="#pone.0096343-Kumar2" class="ref-tip">[32]</a>. H<sub>2</sub>DCFDA is a cell-permeable non-fluorescent indicator for ROS that is oxidized in presence of reactive oxygen species to fluorescent molecule carboxy-DCF. Neuroblastoma cells treated with SsnB for 2 days (SH-SY5Y and IMR-32), 3 days (NGP cells) or 4 days (SKNF-1 and SK-N-BE(2) cells) were labelled with H<sub>2</sub>DCFDA dye for 30 min and cells were immediately examined under fluorescence microscopy. The carboxy-DCF positive cells were quantitated by ImageJ software and plotted. The representative fluorescence images of SH-SY5Y cells in <a href="#pone-0096343-g002">Figure 2A</a> indicated that the number of carboxy-DCF positive cells (green) was significantly increased at 10 µM concentration of SsnB compared to DMSO-treated samples (*<em>p</em>&lt;0.05 <em>vs</em> DMSO; <a href="#pone-0096343-g002">Figure 2B</a>). The ROS generation was observed exclusively in those SsnB treated cells which contain fragmented nuclei (blue). Similar to SH-SY5Y cells, SsnB (10 µM) significantly increased carboxy-DCF positive cells in other neuroblastoma cell lines tested (bar diagram in <a href="#pone-0096343-g002">Figure 2B</a>; *<em>p</em>&lt;0.05 <em>vs</em> DMSO). In negative control, no such green staining was observed in cells processed without H<sub>2</sub>DCFDA dye ruling out the autofluorescence (data not shown). These results suggest that SsnB compound promotes intracellular ROS production in neuroblastoma cell lines. We further evaluated SsnB-induced generation of ROS by fluorometry assay. Neuroblastoma cells as treated above were incubated with H<sub>2</sub>DCFDA dye for 30 min and the fluorescence intensity was measured at 485 nm (excitation wavelength) and 530 nm (emission wavelength). The H<sub>2</sub>DCFDA fluorescence intensity (as measure of generation of ROS) was significantly increased in cells treated with SsnB (10 µM) compared to DMSO control (*<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> DMSO; <a href="#pone-0096343-g002">Figure 2C</a>) whereas the H<sub>2</sub>DCFDA fluorescence intensity levels were almost similar in SsnB (1 µM) and DMSO-treated cells (ns  =  nonsignificant, SsnB 1 µM <em>vs</em> DMSO; <a href="#pone-0096343-g002">Figure 2C</a>).</p>
<a class="link-target" id="pone-0096343-g002" name="pone-0096343-g002"></a><div class="figure" data-doi="10.1371/journal.pone.0096343.g002"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0096343.g002" data-doi="10.1371/journal.pone.0096343" data-uri="10.1371/journal.pone.0096343.g002"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g002" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0096343.g002"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0096343.g002"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0096343.g002"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 2. </span> SsnB induces reactive oxygen species (ROS) generation.</div><p class="caption_target"><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1" class="link-target"></a><p>ROS levels were evaluated by H<sub>2</sub>DCFDA staining after SsnB treatments (1 µM or 10 µM) for 2 days (SH-SY5Y, IMR-32), 3 days (NGP) or 4 days (SKNF-1 and SK-N-BE(2) cells). Signals were examined under fluorescence microscope (<strong>A</strong>); carboxy-DCF positive cells (green) were quantitated by ImageJ programme and plotted (<strong>B</strong>). (<strong>A</strong>) Representative fluorescence images from SH-SY5Y cells showing that compared to DMSO and SsnB (1 µM), SsnB at 10 µM concentration induced ROS generation (green, H<sub>2</sub>DCFDA-positive cells) and signals were exclusively present in cytoplasm (as shown in enlarged images). Nuclei were counterstained with DAPI (blue). Images are representative of at least three independent experiments. Scale bar = 100 µm. (<strong>C</strong>) Bar diagrams representing the fold change in fluorescence intensity of H<sub>2</sub>DCFDA in cells treated with or without SsnB (1 µM or 10 µM) as mentioned above. After labelling with H<sub>2</sub>DCFDA dye (25 µM) for 30 min fluorescence intensity was monitored at excitation wavelength 485 nm and emission wavelength 530 nm. Values are mean and S.D. of three experiments. *<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; ns  =  nonsignificant <em>vs</em> control. (<strong>D</strong> and <strong>E</strong>) ROS generating capacity of SsnB was also evaluated in cell-free system containing H<sub>2</sub>DCFDA (25 µM), horseradish peroxidase (HRP, 5 units/ml), SsnB (10 µM) and GSH (0.25 or 2.5 µM) alone or in combinations. Optical density (OD) at 540 nm were taken at different time points and plotted. (<strong>F</strong>) Neuroblastoma cells treated with SsnB for 2, 3 or 4 days as mentioned above were used to measure cellular glutathione (GSH) levels using luminescence based glutathione assay kit. Values were expressed in % change compared to control samples (considering control as 100%) and plotted. Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; #<em>p</em>≤0.05, SsnB 1 µM <em>vs</em> control.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0096343.g002">
              https://doi.org/10.1371/journal.pone.0096343.g002</a></p></div><a id="article1.body1.sec3.sec3.p2" name="article1.body1.sec3.sec3.p2" class="link-target"></a><p>In a reaction system, after the removal of acetate group by cellular esterases and oxidation by reactive oxygen species, the non-fluorescent carboxy-H<sub>2</sub>DCFDA dye is oxidized to fluorescent molecule carboxy-DCF. To measure the ROS-generating activity of SsnB, we also monitored the oxidation of carboxy-H<sub>2</sub>DCFDA dye in a cell-free system containing carboxy-H<sub>2</sub>DCFDA dye, horseradish peroxidase (HRP) and SsnB at 540 nm <a href="#pone.0096343-Myhre1" class="ref-tip">[38]</a>. HRP was used to supply esterase since without esterase carboxy-H<sub>2</sub>DCFDA is not sensitive to oxidant. As shown in <a href="#pone-0096343-g002">Figure 2D</a>, the optical density (OD) value of reaction containing SsnB (10 µM) + H<sub>2</sub>DCFDA dye (25 µM) remained constant throughout the experiment suggesting that SsnB (10 µM) alone was not able to oxidize H<sub>2</sub>DCFDA to the fluorescent compound carboxy-DCF. After addition of HRP (5 units/ml) in the reaction mixture containing SsnB (10 µM) + H<sub>2</sub>DCFDA dye (25 µM), the OD value increased by 2% in the first 240 sec and further increased by 8% after 15 min compared to H<sub>2</sub>DCFDA + HRP reaction, indicating the increased oxidation of H<sub>2</sub>DCFDA to the fluorescent compound. These results suggest that SsnB in presence of cellular peroxidases oxidizes non-fluorescent H<sub>2</sub>DCFDA dye into the fluorescent compound. Addition of GSH (0.25 µM or 2.5 µM) in a reaction containing SsnB (10 µM) + H<sub>2</sub>DCFDA dye (25 µM) + HRP (5 units/ml) lowers the OD value in a dose dependent manner indicating that GSH as an antioxidant removes the free radicals generated by SsnB in reaction mixture which in turn inhibits the oxidation H<sub>2</sub>DCFDA dye (<a href="#pone-0096343-g002">Figure 2E</a>).</p>
<a id="article1.body1.sec3.sec3.p3" name="article1.body1.sec3.sec3.p3" class="link-target"></a><p>At cellular level, reduced glutathione (GSH) protects cells from oxidative damage resulted from increased superoxides, peroxides and free radicals <a href="#pone.0096343-Martindale1" class="ref-tip">[39]</a>. Since SsnB induces oxidative stress, we asked whether SsnB affects intracellular levels of GSH in neuroblastoma cells. After treatments with SsnB for 2 days (SH-SY5Y and IMR-32), 3 days (NGP cells) or 4 days (SKNF-1 and SK-N-BE(2) cells), the cellular GSH level was measured by luminescence based glutathione assay kit. Compared to control, the GSH level was significantly decreased (∼40% of control) in cells treated with 10 µM SsnB (*<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; <a href="#pone-0096343-g002">Figure 2F</a>). However, the level of GSH at 1 µM SsnB concentration was slightly higher or equals to control levels (#<em>p</em>≤0.05 <em>vs</em> control) suggest that at initial stage basal antioxidant mechanism trying to protect the cell against the toxic effects of SsnB. These results indicated that the GSH depletion was unable to protect neuroblastoma cells against SsnB (10 µM)-induced increased oxidative stress.</p>
</div>

<div id="section4" class="section toc-section"><a id="s3d" name="s3d" class="link-target" title="SsnB Promotes DNA Fragmentation in Neuroblastoma Cells"></a>
<h3>SsnB Promotes DNA Fragmentation in Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1" class="link-target"></a><p>Increased levels of reactive oxygen species (ROS) are known to induce oxidative stress which in turn cleaves DNA that leads to cell death. We next examined SsnB-induced DNA fragmentation in neuroblastoma cells by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay as described previously <a href="#pone.0096343-Kumar2" class="ref-tip">[32]</a>. In this assay, nicked DNA is identified by the addition of fluorophore-labelled dUTPs by enzyme terminal deoxynucleotidyl transferase (TdT) to the terminal ends of damaged DNA in apoptotic cells. The TUNEL-positive cells (green) were quantitated by ImageJ programme and plotted. The number of TUNEL-positive cells at 10 µM concentration of SsnB were significantly higher in all neuroblastoma cells compared to control (*<em>p</em>&lt;0.005 <em>vs</em> control; <a href="#pone-0096343-g003">Figure 3A</a>). The TUNEL-positive cells in SsnB (1 µM) were almost similar to DMSO-treated samples (ns  =  nonsignificant <em>vs</em> control, <em>p</em>&gt;0.05). The representative fluorescence images from SH-SY5Y cells as shown in <a href="#pone-0096343-g003">Figure 3B</a> indicated that SsnB at 10 µM concentration induced DNA fragmentation (green), and the staining for fragmented DNA (TUNEL-positive staining, green in color) and nuclei (blue) were overlapped in a single cell (as shown in enlarged image) suggest that SsnB promotes apoptosis in these cells. However, such TUNEL-positive cells were not detected in DMSO- or SsnB (1 µM)-treated cells.</p>
<a class="link-target" id="pone-0096343-g003" name="pone-0096343-g003"></a><div class="figure" data-doi="10.1371/journal.pone.0096343.g003"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0096343.g003" data-doi="10.1371/journal.pone.0096343" data-uri="10.1371/journal.pone.0096343.g003"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g003" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0096343.g003"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0096343.g003"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0096343.g003"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 3. </span> SsnB induces apoptotic cell death. SsnB-treated neuroblastoma cells (SH-SY5Y and IMR-32 for 2 days, NGP for 3 days, and SKNF-1 and SK-N-BE(2) cells for 4 days) were used to monitor DNA fragmentation by TUNEL assay (A and B), and cleaved caspsase-3 by immunofluorescence (C and D), and Western blotting (E and F).</div><p class="caption_target"><a id="article1.body1.sec3.sec4.fig1.caption1.p1" name="article1.body1.sec3.sec4.fig1.caption1.p1" class="link-target"></a><p>DAPI (blue) was used to stain nuclei. Signals were examined under fluorescence microscope; number of TUNEL-positive cells (green) or cleaved caspase-3 positive cells (green) were counted by ImageJ programme and plotted (<strong>A and C</strong>). Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05 <em>vs</em> control. ns  =  nonsignificant <em>vs</em> control. (<strong>B</strong>) Representative images from SH-SY5Y TUNEL-assay showing that the number of TUNEL-positive cells (green, as indicator of DNA fragmentation) were more in SsnB-treated groups (10 µM) compared to DMSO or SsnB (1 µM). The enlarged overlapped and individual images showing cells with a typical apoptotic nucleus as stained with DAPI (blue) and TUNEL (green), and TUNEL staining is observed in those cells which had fragmented nuclei. Scale bar = 100 µm. (<strong>D</strong>) Representative immunofluorescence images showing staining for cleaved caspase-3 (green) in SH-SY5Y cells. Enlarged single and overlapped images showing that cleaved caspase-3 staining is exclusively present in the cytoplasm. Scale bar = 100 µm. (<strong>E</strong>) Western blot for cleaved caspase-3. Total cell extracts prepared from neuroblastoma cells treated with or without SsnB (1 µM or 10 µM) were separated on 14% SDS-polyacylamide gel and Western blotted with cleaved caspase-3 antibody. β-actin was used to check loading differences. Protein signal intensities were calculated form ImageJ programme and the ratio of cleaved caspase-3/β-actin were plotted (<strong>F</strong>). Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; ns  =  nonsignificant <em>vs</em> control. (<strong>G</strong>) Western blots showing protein expression level for cleaved caspase-3 and p53 in total SH-SY5Y cell extract prepared from SsnB treatment (10 µM) at different time points (6, 12, 24, 48 h). β-actin was used to check loading differences.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0096343.g003">
              https://doi.org/10.1371/journal.pone.0096343.g003</a></p></div></div>

<div id="section5" class="section toc-section"><a id="s3e" name="s3e" class="link-target" title="SsnB Activates Caspase-3 in Neuroblastoma Cells"></a>
<h3>SsnB Activates Caspase-3 in Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1" class="link-target"></a><p>At cellular level, mitochondria- or receptor (Fas/FasL)-mediated pathways activate caspase signaling cascade which in turn induces DNA damage and initiates programmed cell death (apoptosis) <a href="#pone.0096343-Indran1" class="ref-tip">[40]</a>. To determine whether SsnB-induced cell death is mediated by caspase activation, we performed Western blotting as well as immunofluorescence assay to detect active form of caspase-3 in neuroblastoma cells treated with SsnB for 2 days (SH-SY5Y and IMR-32 cells), 3 days (NGP cells) or 4 days (SKNF-1 and SK-N-BE(2) cells). The number of cleaved caspase-3 positive cells (green) were quantitated by ImageJ programme and plotted. The bar diagram in <a href="#pone-0096343-g003">Figure 3C</a> demonstrated that SsnB at 10 µM significantly increased the cleaved caspase-3 positive cells (green) compared to DMSO or SsnB (1 µM) treated neuroblastoma cells (*<em>p</em>&lt;0.005, SsnB 10 µM <em>vs</em> control). The representative immunofluorescence images for SH-SY5Y in <a href="#pone-0096343-g003">Figure 3D</a> indicated that the color intensity of cleaved caspase-3 (green) was significantly increased in SsnB-treated (10 µM) cells and the cleaved caspase-3 fluorescence signals were exclusively present in cytoplasm and did not overlap with nucleus (blue). The corresponding Western blots in <a href="#pone-0096343-g003">Figure 3E</a> demonstrated that the cleaved and active form of caspase-3 protein bands (17 and 19 kDa) were present in protein samples prepared from 10 µM SsnB treated cells (*<em>p</em>&lt;0.005, SsnB 10 µM <em>vs</em> control, <a href="#pone-0096343-g003">Figure 3E and F</a>), while proteins samples from DMSO and SsnB (1 µM) had almost undetectable levels of cleaved caspase-3 (ns  =  nonsignificant, SsnB 1 µM <em>vs</em> control; <a href="#pone-0096343-g003">Figure 3E and F</a>). We further examined the activation of caspase-3 by SsnB (10 µM) at different time points (6, 12, 24 and 48 h) in SH-SY5Y cells. The presence of an active form of caspase-3 protein band (∼19 kDa) showed that SsnB induces cleavage of caspase-3 in these cells even as early as 6 h SsnB exposure (<a href="#pone-0096343-g003">Figure 3G</a>, upper panel). Thus, these data suggest that SsnB induces apoptosis through activation of caspase-3 in all neuroblastoma cell lines tested. We also observed increased expression of p53 in SsnB (10 µM) treated cells compare to DMSO-treated cells (middle panel; <a href="#pone-0096343-g003">Figure 3G</a>). Activation of p53, a tumor suppressor protein, leads to growth arrest at G1 or G2 phase of cell cycle, hence, increased expression of p53 by SsnB suggested that p53 might also involve in SsnB-induced cytotoxicity in p53-containing neuroblastoma cells.</p>
</div>

<div id="section6" class="section toc-section"><a id="s3f" name="s3f" class="link-target" title="SsnB Reduces Expression of N-myc in Neuroblastoma Cells"></a>
<h3>SsnB Reduces Expression of N-myc in Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec6.p1" name="article1.body1.sec3.sec6.p1" class="link-target"></a><p>N-myc proto-oncogene act as a transcription factor, and amplification and overexpression of N-myc gene promotes tumorigenicity in neuroblastoma cells <a href="#pone.0096343-Brodeur2" class="ref-tip">[41]</a>. We evaluated level of N-myc proteins from 2 days (IMR-32), 3 days (NGP cells) or 4 days (SK-N-BE(2) cells) SsnB-treated N-myc amplified neuroblastoma cells by Western blotting, and protein signal intensity was measured by ImageJ programme and plotted. Western blot in <a href="#pone-0096343-g004">Figure 4A</a> demonstrates that SsnB at 10 µM inhibited the expression of N-myc protein in these cell lines (*<em>p</em>&lt;0.005, SsnB 10 µM <em>vs</em> control; <a href="#pone-0096343-g004">Figure 4A and B</a>). However such reduction in protein expression was not observed at 1 µM concentration of SsnB (ns  =  nonsignificant, SsnB 1 µM <em>vs</em> control; <a href="#pone-0096343-g004">Figure 4A and B</a>).</p>
<a class="link-target" id="pone-0096343-g004" name="pone-0096343-g004"></a><div class="figure" data-doi="10.1371/journal.pone.0096343.g004"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0096343.g004" data-doi="10.1371/journal.pone.0096343" data-uri="10.1371/journal.pone.0096343.g004"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g004" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0096343.g004"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0096343.g004"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0096343.g004"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 4. </span> N-myc protein level in IMR-32, NGP and SK-N-BE(2) cells.</div><p class="caption_target"><a id="article1.body1.sec3.sec6.fig1.caption1.p1" name="article1.body1.sec3.sec6.fig1.caption1.p1" class="link-target"></a><p>(A) Representative Western blots for N-myc protein in total cell extract prepared from IMR-32, NGP and SK-N-BE(2) cells treated with or without SsnB (1 µM or 10 µM) for 2 days, 3 days or 4 days, respectively. β-actin was used to check loading differences. (<strong>B</strong>) Bar diagram represents the fold change in N-myc protein signals as measured by imageJ programme. Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; ns  =  nonsignificant <em>vs</em> control.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0096343.g004">
              https://doi.org/10.1371/journal.pone.0096343.g004</a></p></div></div>

<div id="section7" class="section toc-section"><a id="s3g" name="s3g" class="link-target" title="N-acetylcystamine (NAC) Attenuates the Inhibitory Effects of SsnB in Neuroblastoma Cells"></a>
<h3>N-acetylcystamine (NAC) Attenuates the Inhibitory Effects of SsnB in Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec7.p1" name="article1.body1.sec3.sec7.p1" class="link-target"></a><p>The reduced cell viability, increased ROS and decreased GSH levels by SsnB indicated that depletion of glutathione may be a primary cause for the cell death. Next, we examined whether addition of N-acetylcystamine (NAC), a GSH precursor and an antioxidant, can protect neuroblastoma cells from SsnB-induced cell death <a href="#pone.0096343-Zafarullah1" class="ref-tip">[42]</a>. To test this hypothesis, neuroblastoma cells were pretreated with NAC (0.5, 1 and 5 mM) for 1 h followed by treatment with SsnB (10 µM) for 2 days (SH-SY5Y and IMR-32 cells), 3 days (NGP cells) or 4 days (SKNF-1 and SK-N-BE(2) cells), and cell viability was measured by MTT assay. MTT cell viability assays showed that NAC treatment suppresses SsnB-induced cell death in a concentration dependent manner (<a href="#pone-0096343-g005">Figure 5A</a>). SsnB (10 µM) induced neuroblastoma cell death in range of 40–60% (*<em>p</em>&lt;0.05 <em>vs</em> control) whereas presence of NAC (1 mM or 5 mM) significantly increased the viability of SsnB-treated cells (#<em>p</em>&lt;0.05, SsnB 10 µM alone <em>vs</em> SsnB 10 µM + NAC 1 or 5 mM). Next we measured the levels of ROS in SsnB-treated cells preincubated with NAC by fluorometry assay using H<sub>2</sub>DCFDA dye. NAC at 1 and 5 mM concentration significantly reduces ROS levels in SsnB (10 µM) treated neuroblastoma cells (#<em>p</em>&lt;0.05, SsnB 10 µM alone <em>vs</em> SsnB 10 µM + NAC 1 or 5 mM; <a href="#pone-0096343-g005">Figure 5B</a>). These data suggest that NAC as an ROS scavenger removes SsnB-induced generation of reactive oxygen species in cells.</p>
<a class="link-target" id="pone-0096343-g005" name="pone-0096343-g005"></a><div class="figure" data-doi="10.1371/journal.pone.0096343.g005"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0096343.g005" data-doi="10.1371/journal.pone.0096343" data-uri="10.1371/journal.pone.0096343.g005"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g005" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0096343.g005"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0096343.g005"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0096343.g005"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 5. </span> N-acetylcysteine (NAC) attenuates the inhibitory effects of SsnB.</div><p class="caption_target"><a id="article1.body1.sec3.sec7.fig1.caption1.p1" name="article1.body1.sec3.sec7.fig1.caption1.p1" class="link-target"></a><p>(A) Neuroblastoma cells were pretreated with NAC (0.5, 1 or 5 mM) for 1 h followed by SsnB (10 µM) treatment for 2 days (SH-SY5Y and IMR-32), 3 days (NGP) or 4 days (SKNF-1 and SK-N-BE(2) cells) and after treatments MTT cell viability assays was carried out. Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05 <em>vs</em> control; ns  =  nonsignificant <em>vs</em> SsnB 10 µM; #<em>p</em>&lt;0.05 <em>vs</em> SsnB 10 µM. (<strong>B</strong>) Bar diagram representing the fold change in H<sub>2</sub>DCFDA-fluorescence intensity in cells treated with SsnB (10 µM) alone or in combinations with NAC (0.5, 1 or 5 mM) as mentioned above. After labelling with H<sub>2</sub>DCFDA dye (25 µM) for 30 min fluorescence intensity was monitored at excitation wavelength 485 nm and emission wavelength 530 nm. Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05 <em>vs</em> control; ns  =  nonsignificant <em>vs</em> SsnB 10 µM; #<em>p</em>&lt;0.05 <em>vs</em> SsnB 10 µM. (<strong>C</strong>) Representative Western blots demonstrating level of cleaved caspase-3 in total cell protein isolated from SH-SY5Y (upper panel) and SK-N-BE(2) cells (lower panel) treated with NAC (0.5, 1 or 5 mM) and SsnB (10 µM) alone or in combinations for 2 days and 4 days, respectively. β-actin was used to check loading differences. Bar diagram represents the fold change in protein levels as measured by imageJ programme (<strong>D</strong>). Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; ns  =  nonsignificant <em>vs</em> control; #<em>p</em>&lt;0.05 <em>vs</em> SsnB 10 µM.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0096343.g005">
              https://doi.org/10.1371/journal.pone.0096343.g005</a></p></div><a id="article1.body1.sec3.sec7.p2" name="article1.body1.sec3.sec7.p2" class="link-target"></a><p>We further examined cleaved caspase-3 level in SH-SY5Y cells (2 days treatment) and SK-N-BE(2) cells (4 days treatment) incubated with SsnB (10 µM) with or without NAC (0.5, 1 or 5 mM) by Western blotting. Representative blot in <a href="#pone-0096343-g005">Figure 5C</a> and corresponding bar diagram (<a href="#pone-0096343-g005">Figure 5D</a>) demonstrated that pretreatment of NAC (1 and 5 mM) to SsnB treated cells inhibited the activation on caspase-3 and brings to control levels in both SH-SY5Y (upper panel) and SK-N-BE(2) cells (middle panel) (#<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> SsnB 10 µM + NAC 1 or 5 mM).</p>
</div>

<div id="section8" class="section toc-section"><a id="s3h" name="s3h" class="link-target" title="SsnB Reduces the Tumorigenicity of Neuroblastoma Cells"></a>
<h3>SsnB Reduces the Tumorigenicity of Neuroblastoma Cells</h3>
<a id="article1.body1.sec3.sec8.p1" name="article1.body1.sec3.sec8.p1" class="link-target"></a><p>Next we tested if the anti-proliferative activity of SsnB affects the tumor progression property of neuroblastoma cells by performing two layer agarose gel colony formation assays. Agarose gel colony formation assay is an anchorage-independent <em>in vitro</em> cell transformation assay, and mimics the process of <em>in vivo</em> carcinogenesis <a href="#pone.0096343-BaumannKubetzko1" class="ref-tip">[34]</a>. Neuroblastoma cells (N-myc amplified cell, SK-N-BE(2), and N-myc nonamplified cell, SH-SY5Y) were grown in agarose in presence or absence of SsnB (1 µM and 10 µM) and after 45 days number of colonies were counted. The representative phase contrast images in <a href="#pone-0096343-g006">Figure 6A</a> showed that the size of colonies in SsnB 10 µM treated samples were significantly smaller than the control and SsnB (1 µM) treated samples. The representative bar diagram demonstrated that SsnB at 10 µM concentration significantly inhibited the colony formation capability of both cells (*<em>p</em>&lt;0.05, SsnB 10 µM <em>vs</em> control; <a href="#pone-0096343-g006">Figure 6B</a>).</p>
<a class="link-target" id="pone-0096343-g006" name="pone-0096343-g006"></a><div class="figure" data-doi="10.1371/journal.pone.0096343.g006"><div class="img-box"><a title="Click for larger image" href="article/figure/image?size=medium&amp;id=10.1371/journal.pone.0096343.g006" data-doi="10.1371/journal.pone.0096343" data-uri="10.1371/journal.pone.0096343.g006"><img src="article/figure/image?size=inline&amp;id=10.1371/journal.pone.0096343.g006" alt="thumbnail" class="thumbnail" loading="lazy"></a><div class="expand"></div></div><div class="figure-inline-download">
          Download:
          <ul><li><a href="article/figure/powerpoint?id=10.1371/journal.pone.0096343.g006"><div class="definition-label">PPT</div><div class="definition-description">PowerPoint slide</div></a></li><li><a href="article/figure/image?download&amp;size=large&amp;id=10.1371/journal.pone.0096343.g006"><div class="definition-label">PNG</div><div class="definition-description">larger image</div></a></li><li><a href="article/figure/image?download&amp;size=original&amp;id=10.1371/journal.pone.0096343.g006"><div class="definition-label">TIFF</div><div class="definition-description">original image</div></a></li></ul></div><div class="figcaption"><span>Figure 6. </span> SsnB reduces the tumorigenicity of neuroblastoma cells.</div><p class="caption_target"><a id="article1.body1.sec3.sec8.fig1.caption1.p1" name="article1.body1.sec3.sec8.fig1.caption1.p1" class="link-target"></a><p>Phase contrast images showing neuroblastoma colonies formed after treatment with SsnB (1 and 10 µM) for 45 days in anchorage-independent agarose gel colony formation assay (<strong>A</strong>). The number of colonies was counted and plotted (<strong>B</strong>). Bar represents mean and S.D. of three independent experiments and *<em>p</em>&lt;0.05 was considered significant. (<strong>C and D</strong>) SsnB inhibits the neuroblastoma spheroid formation. Phase contrast images showing spheroid formation in absence or presence of SsnB (1 or 10 µM) in 3-D hanging drop assay. Twenty microliter drop containing 20,000 cells (SH-SY5Y, <strong>C</strong>; and SK-N-BE(2) cells, <strong>D</strong>) were pipetted on the lower side of the lid of petri dish. The lid was gently inverted, placed on top of the petri dish and let them grow at 37°C. On day 0, day 1 and day 12 the image of cells in each droplet was taken by Olympus inverted microscope to monitor the spheroid formation. Scale bar = 500 µm.</p>
</p><p class="caption_object"><a href="https://doi.org/10.1371/journal.pone.0096343.g006">
              https://doi.org/10.1371/journal.pone.0096343.g006</a></p></div><a id="article1.body1.sec3.sec8.p2" name="article1.body1.sec3.sec8.p2" class="link-target"></a><p>Since SsnB inhibits the formation of neuroblastoma colony in anchorage-independent agarose gel assay, we further tested if the inhibitory effects of SsnB inhibit the initiation of neuroblastoma tumors in hanging drop assay method. In hanging drop assay the cells under the force of gravity and surface tension start accumulating at the bottom of the hanging drop and join together to form a spheroid. Spheroids represent an <em>in vitro</em> 3D tissue structure that mimics <em>in vivo</em> tumor tissue organization and microenvironment, and 3D culture better reflect cancer cells in their native, <em>in vivo,</em> environment <a href="#pone.0096343-Sodek1" class="ref-tip">[35]</a>. As shown in <a href="#pone-0096343-g006">Figure 6C and D</a>, within 24 hour, both neuroblastoma cells (SH-SY5Y cells, C; and SK-N-BE(2) cells, D) grown in hanging drop culture start aggregating at the bottom of the droplet. On day 12, the shape of the aggregates became rounder and smoother with a gradual decrease in the radius of the spheroid, and form compact cell clusters in DMSO- and SsnB (1 µM)-treated SH-SY5Y and SK-N-BE(2) cells. The decrease in size is the result of higher cell–cell cohesion, which yields more compact aggregates. However, at 10 µM SsnB concentration the cells are loosely attached in spheroids suggesting that SsnB at 10 µM inhibits cell-cell attachment in both cell lines (SH-SY5Y and SK-N-BE(2) cells) as a result these cells are unable to aggregate to form compact spheroids.</p>
</div>
</div>

<div xmlns:plos="http://plos.org" id="section4" class="section toc-section"><a id="s4" name="s4" data-toc="s4" class="link-target" title="Discussion"></a><h2>Discussion</h2><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1" class="link-target"></a><p>Neuroblastoma has heterogeneous population of cells of different genetic background <a href="#pone.0096343-Kamijo1" class="ref-tip">[15]</a>. Increasing evidence supports that molecular and genetic factors such as N-myc oncogene amplification, deletion of short arm of chromosome 1 and high expression of neurotrophin receptors (TrkA and TrkB) are associated with malignant transformation and progression of neuroblastoma. Despite targeting new molecular targets, and the use of multimodal therapy which includes surgery, radiotherapy in conjunction with chemotherapy and monoclonal antibody based immunotherapy, approximately 40% of children with high-risk neuroblastoma remain incurable <a href="#pone.0096343-Morgenstern1" class="ref-tip">[23]</a>, <a href="#pone.0096343-Tonini1" class="ref-tip">[43]</a>, <a href="#pone.0096343-Matthay1" class="ref-tip">[44]</a>. Hence, the identification and development of new therapeutic compounds with less toxicity are urgently needed.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2" class="link-target"></a><p>We used a novel naturally-occurring compound, Sparstolonin B (SsnB), isolated from the tubers of an aquatic Chinese herb, <em>Sparganium stoloniferum</em> <a href="#pone.0096343-Liang1" class="ref-tip">[1]</a>. The crude extract prepared from this herb has anti-spasmodic and anti-tumor properties <a href="#pone.0096343-Li1" class="ref-tip">[4]</a>–<a href="#pone.0096343-Lee1" class="ref-tip">[6]</a>. In the present study SsnB at 10 µM and above concentrations significantly inhibits the growth and viability of human neuroblastoma cells of different genetic background such as N-myc amplified with wild p53 cells (IMR-32 and NGP cells), N-myc amplified with mutated p53 cells (SKN-BE(2) cell), and N-myc nonamplified cell (SH-SY5Y and SKNF-1 cells). However, the sensitivity of these cells towards SsnB is different, SH-SY5Y and IMR-32 cells are sensitive, NGP cells are moderate sensitive, and SKNF-1 and SK-N-BE(2) cells are least sensitive (as shown by cell morphology and MTT cell viability assays in <a href="#pone-0096343-g001">Figure 1A and B</a>). The reduced viability by SsnB losses neuroblastoma cells ability to form compact spheroids that decreases the tumorigenic potential of both N-myc amplified (SK-N-BE(2) cells) and N-myc nonamplified neuroblastoma cells (SH-SY5Y cells) tested as seen in hanging drop method and anchorage-independent colony formation assay (<a href="#pone-0096343-g006">Figure 6</a>). These <em>in vitro</em> 3-D culture results further confirmed the anti-tumorigenic activity of SsnB against human neuroblastoma. The SsnB exerts its inhibitory effects only in neuroblastoma cell lines, and up to ∼100 µM concentration SsnB did not exhibits cytotoxicity towards various normal non-tumor human cells such as human monocytic THP-1 cells, phorbol 12-myristate 13-acetate-differentiated THP-1 macrophages, human umbilical vein endothelial cells and human aortic smooth muscle cells <a href="#pone.0096343-Liang1" class="ref-tip">[1]</a>.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3" class="link-target"></a><p>The inhibitory effects of SsnB on cell growth and viability are resulted from the caspase-mediated cell death (<a href="#pone-0096343-g003">Figure 3C–F</a>). The increased level of activated form of caspase-3 has been shown to trigger DNA fragmentation, chromatin condensation, membrane blebbing and cell shrinkage that leads to the programme cell death called apoptosis <a href="#pone.0096343-Indran1" class="ref-tip">[40]</a>. The presence of apoptotic nuclei in SsnB-treated neuroblastoma cells compared to control DMSO-treated cells (as revealed by TUNEL assay, <a href="#pone-0096343-g003">Figure 3A and B</a>) indicates that activation of caspase cascade by SsnB trigger apoptotic cell death pathways. In addition, we also found that SsnB promotes ROS generation in both N-myc amplified and N-myc nonamplified neuroblastoma cells (<a href="#pone-0096343-g002">Figure 2A–C</a>). The ROS generating capacity of SsnB was confirmed by our cell-free system in which SsnB in presence of peroxidase (HRP) oxidized H<sub>2</sub>DCDA to fluorescent compound (<a href="#pone-0096343-g002">Figure 2D and E</a>). Reactive oxygen species such as free radicals and peroxides increases cellular oxidative stress which promotes lipids peroxidation and oxidation of nucleic acid and amplifies the cell death. The imbalance between the generation of reactive oxygen species (ROS) and antioxidant defense status disrupt the redox homeostasis <a href="#pone.0096343-Martindale1" class="ref-tip">[39]</a>. In our present study, we observed that SsnB significantly decreased glutathione (GSH) level in neuroblastoma cells (<a href="#pone-0096343-g002">Figure 2F</a>). GSH acts as an antioxidant and its role to remove oxidative stress caused by reactive oxygen species is well known hence GSH depletion in presence of SsnB fail to remove free radicals and this might be the primary cause of SsnB-induced cytotoxicity towards neuroblastoma cells. The critical role of GSH in SsnB-induced cytotoxicity was further supported by our observations obtained with N-acetylcystamine (NAC). NAC is a GSH precursor and functions as an antioxidant. Co-incubation of NAC removes free radicals from the SsnB-treated cells and inhibits the activation of cleaved caspase-3 (<a href="#pone-0096343-g005">Figure 5B–D</a>). These events thus protect the cells against the oxidative insults caused by SsnB and increased the cell viability (<a href="#pone-0096343-g005">Figure 5A</a>). Hence these data suggest that SsnB-induced cytotoxic effects are resulted by the excess generation of reactive oxygen species in neuroblastoma cells.</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4" class="link-target"></a><p>The induction of cell cycle arrest at a specific checkpoint and thereby inducing apoptosis is a common mechanism for the cytotoxic effects of anticancer drugs <a href="#pone.0096343-Shapiro1" class="ref-tip">[45]</a>. The cell cycle arrest at G2/M transition is a potential target for cancer therapy as it prevents DNA-damaged cells from entering mitosis, and cell cycle blockage at this checkpoint is carried out by cell cycle-related proteins such as p53 and cyclins. Activation of p53, a tumor suppressor protein, leads to growth arrest at G1 or G2 phase of cell cycle <a href="#pone.0096343-Taylor1" class="ref-tip">[46]</a>. The results in present study demonstrate that treating neuroblastoma cells with SsnB (10 µM) resulted in cell cycle block in G2/M phase (flow cytometry analysis, <a href="#pone-0096343-g001">Figure 1C</a>) and increase in expression of p53 compared to DMSO treated cells (<a href="#pone-0096343-g003">Figure 3G</a>). These findings suggested that p53-mediated apoptosis might also involve in SsnB-induced cytotoxicity in p53-containing neuroblastoma cells.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5" class="link-target"></a><p>It is well known that N-myc amplification is associated with neuroblastoma tumor progression and drug resistance <a href="#pone.0096343-Brodeur2" class="ref-tip">[41]</a>, <a href="#pone.0096343-Schwab2" class="ref-tip">[47]</a>. N-myc, a member of the myc family of proto-oncoprotein, acts as a transcription factor and regulates the expression of genes involved in cell cycle, DNA damage and apoptosis, and overexpression of N-myc in trasnsgenic mice results in neuroblastoma development <a href="#pone.0096343-Weiss1" class="ref-tip">[48]</a>. However, downregulation of N-myc expression has been shown to induce growth arrest and apoptosis in neuroblastoma cells <a href="#pone.0096343-Bell1" class="ref-tip">[49]</a>, <a href="#pone.0096343-Kang1" class="ref-tip">[50]</a>. In the current study, we found that SsnB at 10 µM concentration suppresses the N-myc expression in IMR-32, NGP and SK-N-BE(2) cells (<a href="#pone-0096343-g004">Figure 4</a>) which might be correlated with the SsnB-mediated anticancer activity on human neuroblastoma cells.</p>
<a id="article1.body1.sec4.p6" name="article1.body1.sec4.p6" class="link-target"></a><p>In summary, the present study for the first time demonstrated the anticancer property of SsnB on human neuroblastoma cells. SsnB induces apoptosis in a wide range of neuroblastoma cell lines. The reduced tumorigenic ability of both N-myc amplified and N-myc nonamplified cells resulted from SsnB in our colony formation and hanging drop assays, and a recent published study showing that SsnB exerts anti-angiogenic property by downregulating mRNA level of cell cycle regulatory proteins <a href="#pone.0096343-Bateman1" class="ref-tip">[3]</a> indicated that SsnB can be a used as a novel therapeutics anticancer agent. Drugs that generate ROS and induce apoptosis are used alone or in combination with other therapies to treat cancer, suggesting that SsnB can be a promising antitumor agent for neuroblastoma and requires preclinical studies on animal models <a href="#pone.0096343-Herr1" class="ref-tip">[51]</a>.</p>
</div>



<div xmlns:plos="http://plos.org" class="contributions toc-section"><a id="authcontrib" name="authcontrib" data-toc="authcontrib" title="Author Contributions"></a><h2>Author Contributions</h2><p>Conceived and designed the experiments: AK USS. Performed the experiments: AK. Analyzed the data: AK DF DJD USS. Contributed reagents/materials/analysis tools: DF. Wrote the paper: AK DF DJD USS.</p></div><div xmlns:plos="http://plos.org" class="toc-section"><a id="references" name="references" class="link-target" data-toc="references" title="References"></a><h2>References</h2><ol class="references"><li id="ref1"><span class="order">1.
            </span><a name="pone.0096343-Liang1" id="pone.0096343-Liang1" class="link-target"></a>Liang Q, Wu Q, Jiang J, Duan J, Wang C, et al. (2011) Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties. J Biol Chem 286: 26470–26479. <ul class="reflinks"><li><a href="#" data-author="Liang" data-cit="LiangQ%2C%20WuQ%2C%20JiangJ%2C%20DuanJ%2C%20WangC%2C%20et%20al.%20%282011%29%20Characterization%20of%20sparstolonin%20B%2C%20a%20Chinese%20herb-derived%20compound%2C%20as%20a%20selective%20Toll-like%20receptor%20antagonist%20with%20potent%20anti-inflammatory%20properties.%20J%20Biol%20Chem%20286%3A%2026470%E2%80%9326479." data-title="Characterization%20of%20sparstolonin%20B%2C%20a%20Chinese%20herb-derived%20compound%2C%20as%20a%20selective%20Toll-like%20receptor%20antagonist%20with%20potent%20anti-inflammatory%20properties" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Characterization+of+sparstolonin+B%2C+a+Chinese+herb-derived+compound%2C+as+a+selective+Toll-like+receptor+antagonist+with+potent+anti-inflammatory+properties+Liang+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref2"><span class="order">2.
            </span><a name="pone.0096343-Liang2" id="pone.0096343-Liang2" class="link-target"></a>Liang Q, Yu F, Cui X, Duan J, Wu Q, et al. (2013) Sparstolonin B suppresses lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells. Arch Pharm Res 36: 890–896. <ul class="reflinks"><li><a href="#" data-author="Liang" data-cit="LiangQ%2C%20YuF%2C%20CuiX%2C%20DuanJ%2C%20WuQ%2C%20et%20al.%20%282013%29%20Sparstolonin%20B%20suppresses%20lipopolysaccharide-induced%20inflammation%20in%20human%20umbilical%20vein%20endothelial%20cells.%20Arch%20Pharm%20Res%2036%3A%20890%E2%80%93896." data-title="Sparstolonin%20B%20suppresses%20lipopolysaccharide-induced%20inflammation%20in%20human%20umbilical%20vein%20endothelial%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Sparstolonin+B+suppresses+lipopolysaccharide-induced+inflammation+in+human+umbilical+vein+endothelial+cells+Liang+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref3"><span class="order">3.
            </span><a name="pone.0096343-Bateman1" id="pone.0096343-Bateman1" class="link-target"></a>Bateman HR, Liang Q, Fan D, Rodriguez V, Lessner SM (2013) Sparstolonin B inhibits pro-angiogenic functions and blocks cell cycle progression in endothelial cells. PLoS One 8: e70500. <ul class="reflinks"><li><a href="#" data-author="Bateman" data-cit="BatemanHR%2C%20LiangQ%2C%20FanD%2C%20RodriguezV%2C%20LessnerSM%20%282013%29%20Sparstolonin%20B%20inhibits%20pro-angiogenic%20functions%20and%20blocks%20cell%20cycle%20progression%20in%20endothelial%20cells.%20PLoS%20One%208%3A%20e70500." data-title="Sparstolonin%20B%20inhibits%20pro-angiogenic%20functions%20and%20blocks%20cell%20cycle%20progression%20in%20endothelial%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Sparstolonin+B+inhibits+pro-angiogenic+functions+and+blocks+cell+cycle+progression+in+endothelial+cells+Bateman+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref4"><span class="order">4.
            </span><a name="pone.0096343-Li1" id="pone.0096343-Li1" class="link-target"></a>Li SX, Wang F, Deng XH, Liang SW (2010) A new alkaloid from the stem of Sparganium stoloniferum Buch.-Ham. J Asian Nat Prod Res 12: 331–333. <ul class="reflinks"><li><a href="#" data-author="Li" data-cit="LiSX%2C%20WangF%2C%20DengXH%2C%20LiangSW%20%282010%29%20A%20new%20alkaloid%20from%20the%20stem%20of%20Sparganium%20stoloniferum%20Buch.-Ham.%20J%20Asian%20Nat%20Prod%20Res%2012%3A%20331%E2%80%93333." data-title="A%20new%20alkaloid%20from%20the%20stem%20of%20Sparganium%20stoloniferum%20Buch.-Ham" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=A+new+alkaloid+from+the+stem+of+Sparganium+stoloniferum+Buch.-Ham+Li+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref5"><span class="order">5.
            </span><a name="pone.0096343-Xiong1" id="pone.0096343-Xiong1" class="link-target"></a>Xiong Y, Deng KZ, Guo YQ, Gao WY, Zhang TJ (2009) New chemical constituents from the rhizomes of Sparganium stoloniferum. Arch Pharm Res 32: 717–720. <ul class="reflinks"><li><a href="#" data-author="Xiong" data-cit="XiongY%2C%20DengKZ%2C%20GuoYQ%2C%20GaoWY%2C%20ZhangTJ%20%282009%29%20New%20chemical%20constituents%20from%20the%20rhizomes%20of%20Sparganium%20stoloniferum.%20Arch%20Pharm%20Res%2032%3A%20717%E2%80%93720." data-title="New%20chemical%20constituents%20from%20the%20rhizomes%20of%20Sparganium%20stoloniferum" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=New+chemical+constituents+from+the+rhizomes+of+Sparganium+stoloniferum+Xiong+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref6"><span class="order">6.
            </span><a name="pone.0096343-Lee1" id="pone.0096343-Lee1" class="link-target"></a>Lee SY, Choi SU, Lee JH, Lee DU, Lee KR (2010) A new phenylpropane glycoside from the rhizome of Sparganium stoloniferum. Arch Pharm Res 33: 515–521. <ul class="reflinks"><li><a href="#" data-author="Lee" data-cit="LeeSY%2C%20ChoiSU%2C%20LeeJH%2C%20LeeDU%2C%20LeeKR%20%282010%29%20A%20new%20phenylpropane%20glycoside%20from%20the%20rhizome%20of%20Sparganium%20stoloniferum.%20Arch%20Pharm%20Res%2033%3A%20515%E2%80%93521." data-title="A%20new%20phenylpropane%20glycoside%20from%20the%20rhizome%20of%20Sparganium%20stoloniferum" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=A+new+phenylpropane+glycoside+from+the+rhizome+of+Sparganium+stoloniferum+Lee+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref7"><span class="order">7.
            </span><a name="pone.0096343-Riveiro1" id="pone.0096343-Riveiro1" class="link-target"></a>Riveiro ME, De Kimpe N, Moglioni A, Vazquez R, Monczor F, et al. (2010) Coumarins: old compounds with novel promising therapeutic perspectives. Curr Med Chem 17: 1325–1338. <ul class="reflinks"><li><a href="#" data-author="Riveiro" data-cit="RiveiroME%2C%20De%20KimpeN%2C%20MoglioniA%2C%20VazquezR%2C%20MonczorF%2C%20et%20al.%20%282010%29%20Coumarins%3A%20old%20compounds%20with%20novel%20promising%20therapeutic%20perspectives.%20Curr%20Med%20Chem%2017%3A%201325%E2%80%931338." data-title="Coumarins%3A%20old%20compounds%20with%20novel%20promising%20therapeutic%20perspectives" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Coumarins%3A+old+compounds+with+novel+promising+therapeutic+perspectives+Riveiro+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref8"><span class="order">8.
            </span><a name="pone.0096343-Wu1" id="pone.0096343-Wu1" class="link-target"></a>Wu L, Wang X, Xu W, Farzaneh F, Xu R (2009) The structure and pharmacological functions of coumarins and their derivatives. Curr Med Chem 16: 4236–4260. <ul class="reflinks"><li><a href="#" data-author="Wu" data-cit="WuL%2C%20WangX%2C%20XuW%2C%20FarzanehF%2C%20XuR%20%282009%29%20The%20structure%20and%20pharmacological%20functions%20of%20coumarins%20and%20their%20derivatives.%20Curr%20Med%20Chem%2016%3A%204236%E2%80%934260." data-title="The%20structure%20and%20pharmacological%20functions%20of%20coumarins%20and%20their%20derivatives" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+structure+and+pharmacological+functions+of+coumarins+and+their+derivatives+Wu+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref9"><span class="order">9.
            </span><a name="pone.0096343-Lin1" id="pone.0096343-Lin1" class="link-target"></a>Lin CN, Liou SJ, Lee TH, Chuang YC, Won SJ (1996) Xanthone derivatives as potential anti-cancer drugs. J Pharm Pharmacol 48: 539–544. <ul class="reflinks"><li><a href="#" data-author="Lin" data-cit="LinCN%2C%20LiouSJ%2C%20LeeTH%2C%20ChuangYC%2C%20WonSJ%20%281996%29%20Xanthone%20derivatives%20as%20potential%20anti-cancer%20drugs.%20J%20Pharm%20Pharmacol%2048%3A%20539%E2%80%93544." data-title="Xanthone%20derivatives%20as%20potential%20anti-cancer%20drugs" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Xanthone+derivatives+as+potential+anti-cancer+drugs+Lin+1996" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref10"><span class="order">10.
            </span><a name="pone.0096343-Na1" id="pone.0096343-Na1" class="link-target"></a>Na Y (2009) Recent cancer drug development with xanthone structures. J Pharm Pharmacol 61: 707–712. <ul class="reflinks"><li><a href="#" data-author="Na" data-cit="NaY%20%282009%29%20Recent%20cancer%20drug%20development%20with%20xanthone%20structures.%20J%20Pharm%20Pharmacol%2061%3A%20707%E2%80%93712." data-title="Recent%20cancer%20drug%20development%20with%20xanthone%20structures" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Recent+cancer+drug+development+with+xanthone+structures+Na+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref11"><span class="order">11.
            </span><a name="pone.0096343-Cheung1" id="pone.0096343-Cheung1" class="link-target"></a>Cheung NK, Dyer MA (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 13: 397–411. <ul class="reflinks"><li><a href="#" data-author="Cheung" data-cit="CheungNK%2C%20DyerMA%20%282013%29%20Neuroblastoma%3A%20developmental%20biology%2C%20cancer%20genomics%20and%20immunotherapy.%20Nat%20Rev%20Cancer%2013%3A%20397%E2%80%93411." data-title="Neuroblastoma%3A%20developmental%20biology%2C%20cancer%20genomics%20and%20immunotherapy" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Neuroblastoma%3A+developmental+biology%2C+cancer+genomics+and+immunotherapy+Cheung+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref12"><span class="order">12.
            </span><a name="pone.0096343-Davidoff1" id="pone.0096343-Davidoff1" class="link-target"></a>Davidoff AM (2012) Neuroblastoma. Semin Pediatr Surg 21: 2–14. <ul class="reflinks"><li><a href="#" data-author="Davidoff" data-cit="DavidoffAM%20%282012%29%20Neuroblastoma.%20Semin%20Pediatr%20Surg%2021%3A%202%E2%80%9314." data-title="Neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Neuroblastoma+Davidoff+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref13"><span class="order">13.
            </span><a name="pone.0096343-Ciccarone1" id="pone.0096343-Ciccarone1" class="link-target"></a>Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49: 219–225. <ul class="reflinks"><li><a href="#" data-author="Ciccarone" data-cit="CiccaroneV%2C%20SpenglerBA%2C%20MeyersMB%2C%20BiedlerJL%2C%20RossRA%20%281989%29%20Phenotypic%20diversification%20in%20human%20neuroblastoma%20cells%3A%20expression%20of%20distinct%20neural%20crest%20lineages.%20Cancer%20Res%2049%3A%20219%E2%80%93225." data-title="Phenotypic%20diversification%20in%20human%20neuroblastoma%20cells%3A%20expression%20of%20distinct%20neural%20crest%20lineages" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Phenotypic+diversification+in+human+neuroblastoma+cells%3A+expression+of+distinct+neural+crest+lineages+Ciccarone+1989" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref14"><span class="order">14.
            </span><a name="pone.0096343-Schwab1" id="pone.0096343-Schwab1" class="link-target"></a>Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, et al. (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245–248. <ul class="reflinks"><li><a href="#" data-author="Schwab" data-cit="SchwabM%2C%20AlitaloK%2C%20KlempnauerKH%2C%20VarmusHE%2C%20BishopJM%2C%20et%20al.%20%281983%29%20Amplified%20DNA%20with%20limited%20homology%20to%20myc%20cellular%20oncogene%20is%20shared%20by%20human%20neuroblastoma%20cell%20lines%20and%20a%20neuroblastoma%20tumour.%20Nature%20305%3A%20245%E2%80%93248." data-title="Amplified%20DNA%20with%20limited%20homology%20to%20myc%20cellular%20oncogene%20is%20shared%20by%20human%20neuroblastoma%20cell%20lines%20and%20a%20neuroblastoma%20tumour" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Amplified+DNA+with+limited+homology+to+myc+cellular+oncogene+is+shared+by+human+neuroblastoma+cell+lines+and+a+neuroblastoma+tumour+Schwab+1983" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref15"><span class="order">15.
            </span><a name="pone.0096343-Kamijo1" id="pone.0096343-Kamijo1" class="link-target"></a>Kamijo T, Nakagawara A (2012) Molecular and genetic bases of neuroblastoma. Int J Clin Oncol 17: 190–195. <ul class="reflinks"><li><a href="#" data-author="Kamijo" data-cit="KamijoT%2C%20NakagawaraA%20%282012%29%20Molecular%20and%20genetic%20bases%20of%20neuroblastoma.%20Int%20J%20Clin%20Oncol%2017%3A%20190%E2%80%93195." data-title="Molecular%20and%20genetic%20bases%20of%20neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Molecular+and+genetic+bases+of+neuroblastoma+Kamijo+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref16"><span class="order">16.
            </span><a name="pone.0096343-Brodeur1" id="pone.0096343-Brodeur1" class="link-target"></a>Brodeur GM, Sekhon G, Goldstein MN (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256–2263. <ul class="reflinks"><li><a href="#" data-author="Brodeur" data-cit="BrodeurGM%2C%20SekhonG%2C%20GoldsteinMN%20%281977%29%20Chromosomal%20aberrations%20in%20human%20neuroblastomas.%20Cancer%2040%3A%202256%E2%80%932263." data-title="Chromosomal%20aberrations%20in%20human%20neuroblastomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Chromosomal+aberrations+in+human+neuroblastomas+Brodeur+1977" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref17"><span class="order">17.
            </span><a name="pone.0096343-Gilbert1" id="pone.0096343-Gilbert1" class="link-target"></a>Gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H (1982) Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet 7: 33–42. <ul class="reflinks"><li><a href="#" data-author="Gilbert" data-cit="GilbertF%2C%20BalabanG%2C%20MoorheadP%2C%20BianchiD%2C%20SchlesingerH%20%281982%29%20Abnormalities%20of%20chromosome%201p%20in%20human%20neuroblastoma%20tumors%20and%20cell%20lines.%20Cancer%20Genet%20Cytogenet%207%3A%2033%E2%80%9342." data-title="Abnormalities%20of%20chromosome%201p%20in%20human%20neuroblastoma%20tumors%20and%20cell%20lines" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Abnormalities+of+chromosome+1p+in+human+neuroblastoma+tumors+and+cell+lines+Gilbert+1982" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref18"><span class="order">18.
            </span><a name="pone.0096343-Gilbert2" id="pone.0096343-Gilbert2" class="link-target"></a>Gilbert F, Feder M, Balaban G, Brangman D, Lurie DK, et al. (1984) Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 44: 5444–5449. <ul class="reflinks"><li><a href="#" data-author="Gilbert" data-cit="GilbertF%2C%20FederM%2C%20BalabanG%2C%20BrangmanD%2C%20LurieDK%2C%20et%20al.%20%281984%29%20Human%20neuroblastomas%20and%20abnormalities%20of%20chromosomes%201%20and%2017.%20Cancer%20Res%2044%3A%205444%E2%80%935449." data-title="Human%20neuroblastomas%20and%20abnormalities%20of%20chromosomes%201%20and%2017" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Human+neuroblastomas+and+abnormalities+of+chromosomes+1+and+17+Gilbert+1984" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref19"><span class="order">19.
            </span><a name="pone.0096343-Srivatsan1" id="pone.0096343-Srivatsan1" class="link-target"></a>Srivatsan ES, Murali V, Seeger RC (1991) Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Prog Clin Biol Res 366: 91–98. <ul class="reflinks"><li><a href="#" data-author="Srivatsan" data-cit="SrivatsanES%2C%20MuraliV%2C%20SeegerRC%20%281991%29%20Loss%20of%20heterozygosity%20for%20alleles%20on%20chromosomes%2011q%20and%2014q%20in%20neuroblastoma.%20Prog%20Clin%20Biol%20Res%20366%3A%2091%E2%80%9398." data-title="Loss%20of%20heterozygosity%20for%20alleles%20on%20chromosomes%2011q%20and%2014q%20in%20neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Loss+of+heterozygosity+for+alleles+on+chromosomes+11q+and+14q+in+neuroblastoma+Srivatsan+1991" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref20"><span class="order">20.
            </span><a name="pone.0096343-Imamura1" id="pone.0096343-Imamura1" class="link-target"></a>Imamura J, Bartram CR, Berthold F, Harms D, Nakamura H, et al. (1993) Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 53: 4053–4058. <ul class="reflinks"><li><a href="#" data-author="Imamura" data-cit="ImamuraJ%2C%20BartramCR%2C%20BertholdF%2C%20HarmsD%2C%20NakamuraH%2C%20et%20al.%20%281993%29%20Mutation%20of%20the%20p53%20gene%20in%20neuroblastoma%20and%20its%20relationship%20with%20N-myc%20amplification.%20Cancer%20Res%2053%3A%204053%E2%80%934058." data-title="Mutation%20of%20the%20p53%20gene%20in%20neuroblastoma%20and%20its%20relationship%20with%20N-myc%20amplification" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Mutation+of+the+p53+gene+in+neuroblastoma+and+its+relationship+with+N-myc+amplification+Imamura+1993" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref21"><span class="order">21.
            </span><a name="pone.0096343-Kawamata1" id="pone.0096343-Kawamata1" class="link-target"></a>Kawamata N, Seriu T, Koeffler HP, Bartram CR (1996) Molecular analysis of the cyclin-dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomas. Cancer 77: 570–575. <ul class="reflinks"><li><a href="#" data-author="Kawamata" data-cit="KawamataN%2C%20SeriuT%2C%20KoefflerHP%2C%20BartramCR%20%281996%29%20Molecular%20analysis%20of%20the%20cyclin-dependent%20kinase%20inhibitor%20family%3A%20p16%28CDKN2%2FMTS1%2FINK4A%29%2C%20p18%28INK4C%29%20and%20p27%28Kip1%29%20genes%20in%20neuroblastomas.%20Cancer%2077%3A%20570%E2%80%93575." data-title="Molecular%20analysis%20of%20the%20cyclin-dependent%20kinase%20inhibitor%20family%3A%20p16%28CDKN2%2FMTS1%2FINK4A%29%2C%20p18%28INK4C%29%20and%20p27%28Kip1%29%20genes%20in%20neuroblastomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Molecular+analysis+of+the+cyclin-dependent+kinase+inhibitor+family%3A+p16%28CDKN2%2FMTS1%2FINK4A%29%2C+p18%28INK4C%29+and+p27%28Kip1%29+genes+in+neuroblastomas+Kawamata+1996" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref22"><span class="order">22.
            </span><a name="pone.0096343-Hofstra1" id="pone.0096343-Hofstra1" class="link-target"></a>Hofstra RM, Cheng NC, Hansen C, Stulp RP, Stelwagen T, et al. (1996) No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma. Hum Genet 97: 362–364. <ul class="reflinks"><li><a href="#" data-author="Hofstra" data-cit="HofstraRM%2C%20ChengNC%2C%20HansenC%2C%20StulpRP%2C%20StelwagenT%2C%20et%20al.%20%281996%29%20No%20mutations%20found%20by%20RET%20mutation%20scanning%20in%20sporadic%20and%20hereditary%20neuroblastoma.%20Hum%20Genet%2097%3A%20362%E2%80%93364." data-title="No%20mutations%20found%20by%20RET%20mutation%20scanning%20in%20sporadic%20and%20hereditary%20neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=No+mutations+found+by+RET+mutation+scanning+in+sporadic+and+hereditary+neuroblastoma+Hofstra+1996" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref23"><span class="order">23.
            </span><a name="pone.0096343-Morgenstern1" id="pone.0096343-Morgenstern1" class="link-target"></a>Morgenstern DA, Baruchel S, Irwin MS (2013) Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy. J Pediatr Hematol Oncol 35: 337–347. <ul class="reflinks"><li><a href="#" data-author="Morgenstern" data-cit="MorgensternDA%2C%20BaruchelS%2C%20IrwinMS%20%282013%29%20Current%20and%20future%20strategies%20for%20relapsed%20neuroblastoma%3A%20challenges%20on%20the%20road%20to%20precision%20therapy.%20J%20Pediatr%20Hematol%20Oncol%2035%3A%20337%E2%80%93347." data-title="Current%20and%20future%20strategies%20for%20relapsed%20neuroblastoma%3A%20challenges%20on%20the%20road%20to%20precision%20therapy" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Current+and+future+strategies+for+relapsed+neuroblastoma%3A+challenges+on+the+road+to+precision+therapy+Morgenstern+2013" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref24"><span class="order">24.
            </span><a name="pone.0096343-Sidell1" id="pone.0096343-Sidell1" class="link-target"></a>Sidell N, Altman A, Haussler MR, Seeger RC (1983) Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res 148: 21–30. <ul class="reflinks"><li><a href="#" data-author="Sidell" data-cit="SidellN%2C%20AltmanA%2C%20HausslerMR%2C%20SeegerRC%20%281983%29%20Effects%20of%20retinoic%20acid%20%28RA%29%20on%20the%20growth%20and%20phenotypic%20expression%20of%20several%20human%20neuroblastoma%20cell%20lines.%20Exp%20Cell%20Res%20148%3A%2021%E2%80%9330." data-title="Effects%20of%20retinoic%20acid%20%28RA%29%20on%20the%20growth%20and%20phenotypic%20expression%20of%20several%20human%20neuroblastoma%20cell%20lines" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Effects+of+retinoic+acid+%28RA%29+on+the+growth+and+phenotypic+expression+of+several+human+neuroblastoma+cell+lines+Sidell+1983" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref25"><span class="order">25.
            </span><a name="pone.0096343-Singh1" id="pone.0096343-Singh1" class="link-target"></a>Singh US, Pan J, Kao YL, Joshi S, Young KL, et al. (2003) Tissue Transglutaminase Mediates Activation of RhoA and MAP Kinase Pathways during Retinoic Acid-induced Neuronal Differentiation of SH-SY5Y Cells. J Biol Chem 278: 391–399. <ul class="reflinks"><li><a href="#" data-author="Singh" data-cit="SinghUS%2C%20PanJ%2C%20KaoYL%2C%20JoshiS%2C%20YoungKL%2C%20et%20al.%20%282003%29%20Tissue%20Transglutaminase%20Mediates%20Activation%20of%20RhoA%20and%20MAP%20Kinase%20Pathways%20during%20Retinoic%20Acid-induced%20Neuronal%20Differentiation%20of%20SH-SY5Y%20Cells.%20J%20Biol%20Chem%20278%3A%20391%E2%80%93399." data-title="Tissue%20Transglutaminase%20Mediates%20Activation%20of%20RhoA%20and%20MAP%20Kinase%20Pathways%20during%20Retinoic%20Acid-induced%20Neuronal%20Differentiation%20of%20SH-SY5Y%20Cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Tissue+Transglutaminase+Mediates+Activation+of+RhoA+and+MAP+Kinase+Pathways+during+Retinoic+Acid-induced+Neuronal+Differentiation+of+SH-SY5Y+Cells+Singh+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref26"><span class="order">26.
            </span><a name="pone.0096343-Thiele1" id="pone.0096343-Thiele1" class="link-target"></a>Thiele CJ, Reynolds CP, Israel MA (1985) Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313: 404–406. <ul class="reflinks"><li><a href="#" data-author="Thiele" data-cit="ThieleCJ%2C%20ReynoldsCP%2C%20IsraelMA%20%281985%29%20Decreased%20expression%20of%20N-myc%20precedes%20retinoic%20acid-induced%20morphological%20differentiation%20of%20human%20neuroblastoma.%20Nature%20313%3A%20404%E2%80%93406." data-title="Decreased%20expression%20of%20N-myc%20precedes%20retinoic%20acid-induced%20morphological%20differentiation%20of%20human%20neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Decreased+expression+of+N-myc+precedes+retinoic+acid-induced+morphological+differentiation+of+human+neuroblastoma+Thiele+1985" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref27"><span class="order">27.
            </span><a name="pone.0096343-Joshi1" id="pone.0096343-Joshi1" class="link-target"></a>Joshi S, Guleria RS, Pan J, Dipette D, Singh US (2007) Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation. Biochim Biophys Acta 1772: 1093–1102. <ul class="reflinks"><li><a href="#" data-author="Joshi" data-cit="JoshiS%2C%20GuleriaRS%2C%20PanJ%2C%20DipetteD%2C%20SinghUS%20%282007%29%20Heterogeneity%20in%20retinoic%20acid%20signaling%20in%20neuroblastomas%3A%20Role%20of%20matrix%20metalloproteinases%20in%20retinoic%20acid-induced%20differentiation.%20Biochim%20Biophys%20Acta%201772%3A%201093%E2%80%931102." data-title="Heterogeneity%20in%20retinoic%20acid%20signaling%20in%20neuroblastomas%3A%20Role%20of%20matrix%20metalloproteinases%20in%20retinoic%20acid-induced%20differentiation" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Heterogeneity+in+retinoic+acid+signaling+in+neuroblastomas%3A+Role+of+matrix+metalloproteinases+in+retinoic+acid-induced+differentiation+Joshi+2007" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref28"><span class="order">28.
            </span><a name="pone.0096343-Azar1" id="pone.0096343-Azar1" class="link-target"></a>Azar CG, Scavarda NJ, Reynolds CP, Brodeur GM (1990) Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Differ 1: 421–428. <ul class="reflinks"><li><a href="#" data-author="Azar" data-cit="AzarCG%2C%20ScavardaNJ%2C%20ReynoldsCP%2C%20BrodeurGM%20%281990%29%20Multiple%20defects%20of%20the%20nerve%20growth%20factor%20receptor%20in%20human%20neuroblastomas.%20Cell%20Growth%20Differ%201%3A%20421%E2%80%93428." data-title="Multiple%20defects%20of%20the%20nerve%20growth%20factor%20receptor%20in%20human%20neuroblastomas" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Multiple+defects+of+the+nerve+growth+factor+receptor+in+human+neuroblastomas+Azar+1990" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref29"><span class="order">29.
            </span><a name="pone.0096343-Pozarowski1" id="pone.0096343-Pozarowski1" class="link-target"></a>Pozarowski P, Darzynkiewicz Z (2004) Analysis of cell cycle by flow cytometry. Methods Mol Biol 281: 301–311. <ul class="reflinks"><li><a href="#" data-author="Pozarowski" data-cit="PozarowskiP%2C%20DarzynkiewiczZ%20%282004%29%20Analysis%20of%20cell%20cycle%20by%20flow%20cytometry.%20Methods%20Mol%20Biol%20281%3A%20301%E2%80%93311." data-title="Analysis%20of%20cell%20cycle%20by%20flow%20cytometry" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Analysis+of+cell+cycle+by+flow+cytometry+Pozarowski+2004" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref30"><span class="order">30.
            </span><a name="pone.0096343-Kumar1" id="pone.0096343-Kumar1" class="link-target"></a>Kumar A, Singh CK, DiPette DD, Singh US (2010) Ethanol impairs activation of retinoic acid receptors in cerebellar granule cells in a rodent model of fetal alcohol spectrum disorders. Alcohol Clin Exp Res 34: 928–937. <ul class="reflinks"><li><a href="#" data-author="Kumar" data-cit="KumarA%2C%20SinghCK%2C%20DiPetteDD%2C%20SinghUS%20%282010%29%20Ethanol%20impairs%20activation%20of%20retinoic%20acid%20receptors%20in%20cerebellar%20granule%20cells%20in%20a%20rodent%20model%20of%20fetal%20alcohol%20spectrum%20disorders.%20Alcohol%20Clin%20Exp%20Res%2034%3A%20928%E2%80%93937." data-title="Ethanol%20impairs%20activation%20of%20retinoic%20acid%20receptors%20in%20cerebellar%20granule%20cells%20in%20a%20rodent%20model%20of%20fetal%20alcohol%20spectrum%20disorders" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Ethanol+impairs+activation+of+retinoic+acid+receptors+in+cerebellar+granule+cells+in+a+rodent+model+of+fetal+alcohol+spectrum+disorders+Kumar+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref31"><span class="order">31.
            </span><a name="pone.0096343-Karlsson1" id="pone.0096343-Karlsson1" class="link-target"></a>Karlsson M, Kurz T, Brunk UT, Nilsson SE, Frennesson CI (2010) What does the commonly used DCF test for oxidative stress really show? Biochem J 428: 183–190. <ul class="reflinks"><li><a href="#" data-author="Karlsson" data-cit="KarlssonM%2C%20KurzT%2C%20BrunkUT%2C%20NilssonSE%2C%20FrennessonCI%20%282010%29%20What%20does%20the%20commonly%20used%20DCF%20test%20for%20oxidative%20stress%20really%20show%3F%20Biochem%20J%20428%3A%20183%E2%80%93190." data-title="What%20does%20the%20commonly%20used%20DCF%20test%20for%20oxidative%20stress%20really%20show%3F" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=What+does+the+commonly+used+DCF+test+for+oxidative+stress+really+show%3F+Karlsson+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref32"><span class="order">32.
            </span><a name="pone.0096343-Kumar2" id="pone.0096343-Kumar2" class="link-target"></a>Kumar A, Singh CK, Lavoie HA, Dipette DJ, Singh US (2011) Resveratrol restores Nrf2 level and prevents ethanol-induced toxic effects in the cerebellum of a rodent model of fetal alcohol spectrum disorders. Mol Pharmacol 80: 446–457. <ul class="reflinks"><li><a href="#" data-author="Kumar" data-cit="KumarA%2C%20SinghCK%2C%20LavoieHA%2C%20DipetteDJ%2C%20SinghUS%20%282011%29%20Resveratrol%20restores%20Nrf2%20level%20and%20prevents%20ethanol-induced%20toxic%20effects%20in%20the%20cerebellum%20of%20a%20rodent%20model%20of%20fetal%20alcohol%20spectrum%20disorders.%20Mol%20Pharmacol%2080%3A%20446%E2%80%93457." data-title="Resveratrol%20restores%20Nrf2%20level%20and%20prevents%20ethanol-induced%20toxic%20effects%20in%20the%20cerebellum%20of%20a%20rodent%20model%20of%20fetal%20alcohol%20spectrum%20disorders" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Resveratrol+restores+Nrf2+level+and+prevents+ethanol-induced+toxic+effects+in+the+cerebellum+of+a+rodent+model+of+fetal+alcohol+spectrum+disorders+Kumar+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref33"><span class="order">33.
            </span><a name="pone.0096343-Zhang1" id="pone.0096343-Zhang1" class="link-target"></a>Zhang H, Limphong P, Pieper J, Liu Q, Rodesch CK, et al. (2012) Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity. FASEB J 26: 1442–1451. <ul class="reflinks"><li><a href="#" data-author="Zhang" data-cit="ZhangH%2C%20LimphongP%2C%20PieperJ%2C%20LiuQ%2C%20RodeschCK%2C%20et%20al.%20%282012%29%20Glutathione-dependent%20reductive%20stress%20triggers%20mitochondrial%20oxidation%20and%20cytotoxicity.%20FASEB%20J%2026%3A%201442%E2%80%931451." data-title="Glutathione-dependent%20reductive%20stress%20triggers%20mitochondrial%20oxidation%20and%20cytotoxicity" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Glutathione-dependent+reductive+stress+triggers+mitochondrial+oxidation+and+cytotoxicity+Zhang+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref34"><span class="order">34.
            </span><a name="pone.0096343-BaumannKubetzko1" id="pone.0096343-BaumannKubetzko1" class="link-target"></a>Baumann Kubetzko FB, Di Paolo C, Maag C, Meier R, Schafer BW, et al. (2004) The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line. Carcinogenesis 25: 1839–1846. <ul class="reflinks"><li><a href="#" data-author="Baumann%20Kubetzko" data-cit="Baumann%20KubetzkoFB%2C%20Di%20PaoloC%2C%20MaagC%2C%20MeierR%2C%20SchaferBW%2C%20et%20al.%20%282004%29%20The%20PAX5%20oncogene%20is%20expressed%20in%20N-type%20neuroblastoma%20cells%20and%20increases%20tumorigenicity%20of%20a%20S-type%20cell%20line.%20Carcinogenesis%2025%3A%201839%E2%80%931846." data-title="The%20PAX5%20oncogene%20is%20expressed%20in%20N-type%20neuroblastoma%20cells%20and%20increases%20tumorigenicity%20of%20a%20S-type%20cell%20line" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+PAX5+oncogene+is+expressed+in+N-type+neuroblastoma+cells+and+increases+tumorigenicity+of+a+S-type+cell+line+Baumann+Kubetzko+2004" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref35"><span class="order">35.
            </span><a name="pone.0096343-Sodek1" id="pone.0096343-Sodek1" class="link-target"></a>Sodek KL, Ringuette MJ, Brown TJ (2009) Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 124: 2060–2070. <ul class="reflinks"><li><a href="#" data-author="Sodek" data-cit="SodekKL%2C%20RinguetteMJ%2C%20BrownTJ%20%282009%29%20Compact%20spheroid%20formation%20by%20ovarian%20cancer%20cells%20is%20associated%20with%20contractile%20behavior%20and%20an%20invasive%20phenotype.%20Int%20J%20Cancer%20124%3A%202060%E2%80%932070." data-title="Compact%20spheroid%20formation%20by%20ovarian%20cancer%20cells%20is%20associated%20with%20contractile%20behavior%20and%20an%20invasive%20phenotype" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Compact+spheroid+formation+by+ovarian+cancer+cells+is+associated+with+contractile+behavior+and+an+invasive+phenotype+Sodek+2009" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref36"><span class="order">36.
            </span><a name="pone.0096343-Du1" id="pone.0096343-Du1" class="link-target"></a>Du J, Daniels DH, Asbury C, Venkataraman S, Liu J, et al. (2006) Mitochondrial production of reactive oxygen species mediate dicumarol-induced cytotoxicity in cancer cells. J Biol Chem 281: 37416–37426. <ul class="reflinks"><li><a href="#" data-author="Du" data-cit="DuJ%2C%20DanielsDH%2C%20AsburyC%2C%20VenkataramanS%2C%20LiuJ%2C%20et%20al.%20%282006%29%20Mitochondrial%20production%20of%20reactive%20oxygen%20species%20mediate%20dicumarol-induced%20cytotoxicity%20in%20cancer%20cells.%20J%20Biol%20Chem%20281%3A%2037416%E2%80%9337426." data-title="Mitochondrial%20production%20of%20reactive%20oxygen%20species%20mediate%20dicumarol-induced%20cytotoxicity%20in%20cancer%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Mitochondrial+production+of+reactive+oxygen+species+mediate+dicumarol-induced+cytotoxicity+in+cancer+cells+Du+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref37"><span class="order">37.
            </span><a name="pone.0096343-Yin1" id="pone.0096343-Yin1" class="link-target"></a>Yin L, Ohno T, Weichselbaum R, Kharbanda S, Kufe D (2001) The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen species. Mol Cancer Ther 1: 43–48. <ul class="reflinks"><li><a href="#" data-author="Yin" data-cit="YinL%2C%20OhnoT%2C%20WeichselbaumR%2C%20KharbandaS%2C%20KufeD%20%282001%29%20The%20novel%20isocoumarin%202-%288-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl%29%20propionic%20acid%20%28NM-3%29%20induces%20lethality%20of%20human%20carcinoma%20cells%20by%20generation%20of%20reactive%20oxygen%20species.%20Mol%20Cancer%20Ther%201%3A%2043%E2%80%9348." data-title="The%20novel%20isocoumarin%202-%288-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl%29%20propionic%20acid%20%28NM-3%29%20induces%20lethality%20of%20human%20carcinoma%20cells%20by%20generation%20of%20reactive%20oxygen%20species" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=The+novel+isocoumarin+2-%288-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl%29+propionic+acid+%28NM-3%29+induces+lethality+of+human+carcinoma+cells+by+generation+of+reactive+oxygen+species+Yin+2001" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref38"><span class="order">38.
            </span><a name="pone.0096343-Myhre1" id="pone.0096343-Myhre1" class="link-target"></a>Myhre O, Andersen JM, Aarnes H, Fonnum F (2003) Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 65: 1575–1582. <ul class="reflinks"><li><a href="#" data-author="Myhre" data-cit="MyhreO%2C%20AndersenJM%2C%20AarnesH%2C%20FonnumF%20%282003%29%20Evaluation%20of%20the%20probes%202%E2%80%B2%2C7%E2%80%B2-dichlorofluorescin%20diacetate%2C%20luminol%2C%20and%20lucigenin%20as%20indicators%20of%20reactive%20species%20formation.%20Biochem%20Pharmacol%2065%3A%201575%E2%80%931582." data-title="Evaluation%20of%20the%20probes%202%E2%80%B2%2C7%E2%80%B2-dichlorofluorescin%20diacetate%2C%20luminol%2C%20and%20lucigenin%20as%20indicators%20of%20reactive%20species%20formation" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Evaluation+of+the+probes+2%E2%80%B2%2C7%E2%80%B2-dichlorofluorescin+diacetate%2C+luminol%2C+and+lucigenin+as+indicators+of+reactive+species+formation+Myhre+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref39"><span class="order">39.
            </span><a name="pone.0096343-Martindale1" id="pone.0096343-Martindale1" class="link-target"></a>Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1–15. <ul class="reflinks"><li><a href="#" data-author="Martindale" data-cit="MartindaleJL%2C%20HolbrookNJ%20%282002%29%20Cellular%20response%20to%20oxidative%20stress%3A%20signaling%20for%20suicide%20and%20survival.%20J%20Cell%20Physiol%20192%3A%201%E2%80%9315." data-title="Cellular%20response%20to%20oxidative%20stress%3A%20signaling%20for%20suicide%20and%20survival" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Cellular+response+to+oxidative+stress%3A+signaling+for+suicide+and+survival+Martindale+2002" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref40"><span class="order">40.
            </span><a name="pone.0096343-Indran1" id="pone.0096343-Indran1" class="link-target"></a>Indran IR, Tufo G, Pervaiz S, Brenner C (2011) Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta 1807: 735–745. <ul class="reflinks"><li><a href="#" data-author="Indran" data-cit="IndranIR%2C%20TufoG%2C%20PervaizS%2C%20BrennerC%20%282011%29%20Recent%20advances%20in%20apoptosis%2C%20mitochondria%20and%20drug%20resistance%20in%20cancer%20cells.%20Biochim%20Biophys%20Acta%201807%3A%20735%E2%80%93745." data-title="Recent%20advances%20in%20apoptosis%2C%20mitochondria%20and%20drug%20resistance%20in%20cancer%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Recent+advances+in+apoptosis%2C+mitochondria+and+drug+resistance+in+cancer+cells+Indran+2011" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref41"><span class="order">41.
            </span><a name="pone.0096343-Brodeur2" id="pone.0096343-Brodeur2" class="link-target"></a>Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121–1124. <ul class="reflinks"><li><a href="#" data-author="Brodeur" data-cit="BrodeurGM%2C%20SeegerRC%2C%20SchwabM%2C%20VarmusHE%2C%20BishopJM%20%281984%29%20Amplification%20of%20N-myc%20in%20untreated%20human%20neuroblastomas%20correlates%20with%20advanced%20disease%20stage.%20Science%20224%3A%201121%E2%80%931124." data-title="Amplification%20of%20N-myc%20in%20untreated%20human%20neuroblastomas%20correlates%20with%20advanced%20disease%20stage" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Amplification+of+N-myc+in+untreated+human+neuroblastomas+correlates+with+advanced+disease+stage+Brodeur+1984" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref42"><span class="order">42.
            </span><a name="pone.0096343-Zafarullah1" id="pone.0096343-Zafarullah1" class="link-target"></a>Zafarullah M, Li WQ, Sylvester J, Ahmad M (2003) Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60: 6–20. <ul class="reflinks"><li><a href="#" data-author="Zafarullah" data-cit="ZafarullahM%2C%20LiWQ%2C%20SylvesterJ%2C%20AhmadM%20%282003%29%20Molecular%20mechanisms%20of%20N-acetylcysteine%20actions.%20Cell%20Mol%20Life%20Sci%2060%3A%206%E2%80%9320." data-title="Molecular%20mechanisms%20of%20N-acetylcysteine%20actions" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Molecular+mechanisms+of+N-acetylcysteine+actions+Zafarullah+2003" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref43"><span class="order">43.
            </span><a name="pone.0096343-Tonini1" id="pone.0096343-Tonini1" class="link-target"></a>Tonini GP, Nakagawara A, Berthold F (2012) Towards a turning point of neuroblastoma therapy. Cancer Lett 326: 128–134. <ul class="reflinks"><li><a href="#" data-author="Tonini" data-cit="ToniniGP%2C%20NakagawaraA%2C%20BertholdF%20%282012%29%20Towards%20a%20turning%20point%20of%20neuroblastoma%20therapy.%20Cancer%20Lett%20326%3A%20128%E2%80%93134." data-title="Towards%20a%20turning%20point%20of%20neuroblastoma%20therapy" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Towards+a+turning+point+of+neuroblastoma+therapy+Tonini+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref44"><span class="order">44.
            </span><a name="pone.0096343-Matthay1" id="pone.0096343-Matthay1" class="link-target"></a>Matthay KK, George RE, Yu AL (2012) Promising therapeutic targets in neuroblastoma. Clin Cancer Res 18: 2740–2753. <ul class="reflinks"><li><a href="#" data-author="Matthay" data-cit="MatthayKK%2C%20GeorgeRE%2C%20YuAL%20%282012%29%20Promising%20therapeutic%20targets%20in%20neuroblastoma.%20Clin%20Cancer%20Res%2018%3A%202740%E2%80%932753." data-title="Promising%20therapeutic%20targets%20in%20neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Promising+therapeutic+targets+in+neuroblastoma+Matthay+2012" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref45"><span class="order">45.
            </span><a name="pone.0096343-Shapiro1" id="pone.0096343-Shapiro1" class="link-target"></a>Shapiro GI, Harper JW (1999) Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest 104: 1645–1653. <ul class="reflinks"><li><a href="#" data-author="Shapiro" data-cit="ShapiroGI%2C%20HarperJW%20%281999%29%20Anticancer%20drug%20targets%3A%20cell%20cycle%20and%20checkpoint%20control.%20J%20Clin%20Invest%20104%3A%201645%E2%80%931653." data-title="Anticancer%20drug%20targets%3A%20cell%20cycle%20and%20checkpoint%20control" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Anticancer+drug+targets%3A+cell+cycle+and+checkpoint+control+Shapiro+1999" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref46"><span class="order">46.
            </span><a name="pone.0096343-Taylor1" id="pone.0096343-Taylor1" class="link-target"></a>Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53. Oncogene 20: 1803–1815. <ul class="reflinks"><li><a href="#" data-author="Taylor" data-cit="TaylorWR%2C%20StarkGR%20%282001%29%20Regulation%20of%20the%20G2%2FM%20transition%20by%20p53.%20Oncogene%2020%3A%201803%E2%80%931815." data-title="Regulation%20of%20the%20G2%2FM%20transition%20by%20p53" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Regulation+of+the+G2%2FM+transition+by+p53+Taylor+2001" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref47"><span class="order">47.
            </span><a name="pone.0096343-Schwab2" id="pone.0096343-Schwab2" class="link-target"></a>Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, et al. (1984) Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci U S A 81: 4940–4944. <ul class="reflinks"><li><a href="#" data-author="Schwab" data-cit="SchwabM%2C%20EllisonJ%2C%20BuschM%2C%20RosenauW%2C%20VarmusHE%2C%20et%20al.%20%281984%29%20Enhanced%20expression%20of%20the%20human%20gene%20N-myc%20consequent%20to%20amplification%20of%20DNA%20may%20contribute%20to%20malignant%20progression%20of%20neuroblastoma.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A%2081%3A%204940%E2%80%934944." data-title="Enhanced%20expression%20of%20the%20human%20gene%20N-myc%20consequent%20to%20amplification%20of%20DNA%20may%20contribute%20to%20malignant%20progression%20of%20neuroblastoma" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Enhanced+expression+of+the+human+gene+N-myc+consequent+to+amplification+of+DNA+may+contribute+to+malignant+progression+of+neuroblastoma+Schwab+1984" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref48"><span class="order">48.
            </span><a name="pone.0096343-Weiss1" id="pone.0096343-Weiss1" class="link-target"></a>Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice. Embo J 16: 2985–2995. <ul class="reflinks"><li><a href="#" data-author="Weiss" data-cit="WeissWA%2C%20AldapeK%2C%20MohapatraG%2C%20FeuersteinBG%2C%20BishopJM%20%281997%29%20Targeted%20expression%20of%20MYCN%20causes%20neuroblastoma%20in%20transgenic%20mice.%20Embo%20J%2016%3A%202985%E2%80%932995." data-title="Targeted%20expression%20of%20MYCN%20causes%20neuroblastoma%20in%20transgenic%20mice" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Targeted+expression+of+MYCN+causes+neuroblastoma+in+transgenic+mice+Weiss+1997" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref49"><span class="order">49.
            </span><a name="pone.0096343-Bell1" id="pone.0096343-Bell1" class="link-target"></a>Bell E, Chen L, Liu T, Marshall GM, Lunec J, et al. (2010) MYCN oncoprotein targets and their therapeutic potential. Cancer Lett 293: 144–157. <ul class="reflinks"><li><a href="#" data-author="Bell" data-cit="BellE%2C%20ChenL%2C%20LiuT%2C%20MarshallGM%2C%20LunecJ%2C%20et%20al.%20%282010%29%20MYCN%20oncoprotein%20targets%20and%20their%20therapeutic%20potential.%20Cancer%20Lett%20293%3A%20144%E2%80%93157." data-title="MYCN%20oncoprotein%20targets%20and%20their%20therapeutic%20potential" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=MYCN+oncoprotein+targets+and+their+therapeutic+potential+Bell+2010" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref50"><span class="order">50.
            </span><a name="pone.0096343-Kang1" id="pone.0096343-Kang1" class="link-target"></a>Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, et al. (2006) MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem Biophys Res Commun 351: 192–197. <ul class="reflinks"><li><a href="#" data-author="Kang" data-cit="KangJH%2C%20RychahouPG%2C%20IsholaTA%2C%20QiaoJ%2C%20EversBM%2C%20et%20al.%20%282006%29%20MYCN%20silencing%20induces%20differentiation%20and%20apoptosis%20in%20human%20neuroblastoma%20cells.%20Biochem%20Biophys%20Res%20Commun%20351%3A%20192%E2%80%93197." data-title="MYCN%20silencing%20induces%20differentiation%20and%20apoptosis%20in%20human%20neuroblastoma%20cells" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=MYCN+silencing+induces+differentiation+and+apoptosis+in+human+neuroblastoma+cells+Kang+2006" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li><li id="ref51"><span class="order">51.
            </span><a name="pone.0096343-Herr1" id="pone.0096343-Herr1" class="link-target"></a>Herr I, Debatin KM (2001) Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603–2614. <ul class="reflinks"><li><a href="#" data-author="Herr" data-cit="HerrI%2C%20DebatinKM%20%282001%29%20Cellular%20stress%20response%20and%20apoptosis%20in%20cancer%20therapy.%20Blood%2098%3A%202603%E2%80%932614." data-title="Cellular%20stress%20response%20and%20apoptosis%20in%20cancer%20therapy" target="_new" title="Go to article in CrossRef">
                      View Article
                    </a></li><li><a href="http://scholar.google.com/scholar?q=Cellular+stress+response+and+apoptosis+in+cancer+therapy+Herr+2001" target="_new" title="Go to article in Google Scholar">
                      Google Scholar
                    </a></li></ul></li></ol></div>



          <div class="ref-tooltip">
            <div class="ref_tooltip-content">

            </div>
          </div>

        </div>
      </div>
    </div>

  </section>
  <aside class="article-aside">


<!--[if IE 9]>
<style>
.dload-xml {margin-top: 38px}
</style>
<![endif]-->
<div class="dload-menu">
  <div class="dload-pdf">
    <a href="/plosone/article/file?id=10.1371/journal.pone.0096343&type=printable"
       id="downloadPdf" target="_blank">Download PDF</a>
  </div>
  <div data-js-tooltip-hover="trigger" class="dload-hover">&nbsp;
    <ul class="dload-xml" data-js-tooltip-hover="target">
      <li><a href="/plosone/article/citation?id=10.1371/journal.pone.0096343"
             id="downloadCitation">Citation</a></li>
      <li><a href="/plosone/article/file?id=10.1371/journal.pone.0096343&type=manuscript"
             id="downloadXml">XML</a>
      </li>
    </ul>

  </div>
</div>

<div class="aside-container">

<div class="print-article" id="printArticle" data-js-tooltip-hover="trigger">

  Print
  <ul class="print-options" data-js-tooltip-hover="target">
    <li><a href="#" onclick="window.print(); return false;" class="preventDefault" id="printBrowser">Print article</a></li>

<li><a href="http://surveys.plos.org/s3/reprints">Reprints</a></li>

  </ul>
</div>

<div class="share-article" id="shareArticle" data-js-tooltip-hover="trigger">
  Share
  <ul data-js-tooltip-hover="target" class="share-options" id="share-options">

<li><a href="https://www.reddit.com/submit?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0096343" id="shareReddit" target="_blank" title="Submit to Reddit"><img src="/resource/img/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

<li><a href="https://www.facebook.com/share.php?u=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0096343&t=Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells" id="shareFacebook" target="_blank" title="Share on Facebook"><img src="/resource/img/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>


<li><a href="https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0096343&title=Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells&summary=Checkout this article I found at PLOS"  id="shareLinkedIn" target="_blank" title="Add to LinkedIn"><img src="/resource/img/icon.linkedin.16.png" width="16" height="16" alt="LinkedIn">LinkedIn</a></li>

<li><a href="https://www.mendeley.com/import/?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0096343"  id="shareMendeley" target="_blank" title="Add to Mendeley"><img src="/resource/img/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

  <li><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0096343&text=%23PLOSONE%3A%20Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells" target="_blank" title="share on Twitter" id="twitter-share-link"><img src="/resource/img/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

<li><a href="mailto:?subject=Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells&body=I%20thought%20you%20would%20find%20this%20article%20interesting.%20From%20PLOS ONE:%20https%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0096343"  id="shareEmail" rel="noreferrer" aria-label="Email"><img src="/resource/img/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
<script src="/resource/js/components/tweet140.js" type="text/javascript"></script>
  </ul>
</div></div>


     <!-- Crossmark 2.0 widget -->
    <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script>
    <a aria-label="Check for updates via CrossMark" data-target="crossmark">
      <img alt="Check for updates via CrossMark" width="150" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_BW_horizontal.svg">
    </a>
    <!-- End Crossmark 2.0 widget -->


  <div class="related-articles-container">
    <h3>
Related PLOS Articles
</h3>
    <ul class="related-articles">
        <li>
          <b>
            has CORRECTION
            
          </b>
        </li>
            <li>
<?xml version="1.0" encoding="UTF-8"?>Correction: Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells              <ul class="related-article-links">
                <li class="related-article-link-page">
                  <a href="/plosone/article?id=10.1371/journal.pone.0159082">View Page</a>
                </li>
                <!--  Annotations and issue images do not have printables. They can be filtered by doi. -->
                  <li class="related-article-link-download">
                    <a href="/plosone/article/file?type=printable&id=10.1371/journal.pone.0159082"
                       target="_blank" title="PDF opens in new window">PDF</a>
                  </li>
              </ul>
            </li>
    </ul>
  </div>


<script type="text/javascript">
  var articleDoi = "10.1371/journal.pone.0096343";
  $.ajax({
    url: "https://frontpage.plos.org/wp-json/collections-api/contains",
    data: {id: articleDoi},
    context: document.body,
    timeout: 10000,
    dataType: "json",
    success: function (result, textStatus, xOptions) {
      if (result.response == "success" && result.data.collections.length > 0) {
        var articleCollectionsTemplate = _.template($('#articleCollectionsTemplate').html());
        var articleCollectionsHTML = articleCollectionsTemplate(result.data)
        $('.collections-aside-container').append(articleCollectionsHTML);
      }
    }
  });
</script>

<script type="text/template" id="articleCollectionsTemplate">
  <h3>Included in the Following <% if (collections.length == 1) { %>Collection<% } else { %>Collections<% } %></h3>
  <ul id="collectionList">
  <% _.each(collections, function (collection) { %>
    <li>
      <a href="<%= collection.permalink %>"><%= collection.title %></a>
    </li>
  <% }); %>
  </ul>
</script>

<div class="aside-container collections-aside-container">
</div>


<div class="skyscraper-container">
  <div class="title">Advertisement</div>
<!-- DoubleClick Ad Zone -->
  <div class='advertisement' id='div-gpt-ad-1458247671871-1' style='width:160px; height:600px;'>
    <script type='text/javascript'>
      googletag.cmd.push(function() { googletag.display('div-gpt-ad-1458247671871-1'); });
    </script>
  </div>
</div>




<div class="subject-areas-container">
  <h3>Subject Areas <div id="subjInfo">?</div>
    <div id="subjInfoText">
      <p>For more information about PLOS Subject Areas, click
        <a href="https://github.com/PLOS/plos-thesaurus/blob/master/README.md" target="_blank" title="Link opens in new window">here</a>.</p>
      <span class="inline-intro">We want your feedback.</span> Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!


    </div>
  </h3>
  <ul id="subjectList">
      <li>
              <a class="taxo-term" title="Search for articles about Neuroblastoma cells"
                 href="/plosone/search?filterSubjects=Neuroblastoma+cells&filterJournals=PLoSONE&q=">Neuroblastoma cells</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Neuroblastoma cells"><p class="taxo-explain">Is the Subject Area <strong>"Neuroblastoma cells"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Reactive oxygen species"
                 href="/plosone/search?filterSubjects=Reactive+oxygen+species&filterJournals=PLoSONE&q=">Reactive oxygen species</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Reactive oxygen species"><p class="taxo-explain">Is the Subject Area <strong>"Reactive oxygen species"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Apoptosis"
                 href="/plosone/search?filterSubjects=Apoptosis&filterJournals=PLoSONE&q=">Apoptosis</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Apoptosis"><p class="taxo-explain">Is the Subject Area <strong>"Apoptosis"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Cell cycle and cell division"
                 href="/plosone/search?filterSubjects=Cell+cycle+and+cell+division&filterJournals=PLoSONE&q=">Cell cycle and cell division</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Cell cycle and cell division"><p class="taxo-explain">Is the Subject Area <strong>"Cell cycle and cell division"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Neuroblastoma"
                 href="/plosone/search?filterSubjects=Neuroblastoma&filterJournals=PLoSONE&q=">Neuroblastoma</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Neuroblastoma"><p class="taxo-explain">Is the Subject Area <strong>"Neuroblastoma"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Cancer treatment"
                 href="/plosone/search?filterSubjects=Cancer+treatment&filterJournals=PLoSONE&q=">Cancer treatment</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Cancer treatment"><p class="taxo-explain">Is the Subject Area <strong>"Cancer treatment"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about MTT assay"
                 href="/plosone/search?filterSubjects=MTT+assay&filterJournals=PLoSONE&q=">MTT assay</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="MTT assay"><p class="taxo-explain">Is the Subject Area <strong>"MTT assay"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
      <li>
              <a class="taxo-term" title="Search for articles about Malignant tumors"
                 href="/plosone/search?filterSubjects=Malignant+tumors&filterJournals=PLoSONE&q=">Malignant tumors</a>
        <span class="taxo-flag">&nbsp;</span>
        <div class="taxo-tooltip" data-categoryname="Malignant tumors"><p class="taxo-explain">Is the Subject Area <strong>"Malignant tumors"</strong> applicable to this article?
          <button id="noFlag" data-action="remove">Yes</button>
          <button id="flagIt" value="flagno" data-action="add">No</button></p>
          <p class="taxo-confirm">Thanks for your feedback.</p>
        </div>
      </li>
  </ul>
</div>
<div id="subjectErrors"></div>
  </aside>
</div>




</main>
<footer id="pageftr">
  <div class="row">
    <div class="block x-small">

<ul class="nav nav-secondary">
    <li class="ftr-header"><a href="https://plos.org/publications/journals/">Publications</a></li>
    <li><a href="/plosbiology/" id="ftr-bio">PLOS Biology</a></li>
    <li><a href="/plosmedicine/" id="ftr-med">PLOS Medicine</a></li>
    <li><a href="/ploscompbiol/" id="ftr-compbio">PLOS Computational Biology</a></li>
    <li><a href="/plosgenetics/" id="ftr-gen">PLOS Genetics</a></li>
    <li><a href="/plospathogens/" id="ftr-path">PLOS Pathogens</a></li>
    <li><a href="/plosone/" id="ftr-one">PLOS ONE</a></li>
    <li><a href="/plosntds/" id="ftr-ntds">PLOS Neglected Tropical Diseases</a></li>
  </ul>
    </div>
    <div class="block x-small">

<ul class="nav nav-secondary">
    <li class="ftr-header">&nbsp;</li>
    <li><a href="/climate/" id="ftr-climate">PLOS Climate</a></li>
    <li><a href="/digitalhealth/" id="ftr-digitalhealth">PLOS Digital Health</a></li>
    <li><a href="/globalpublichealth/" id="ftr-globalpublichealth">PLOS Global Public Health</a></li>
    <li><a href="/sustainabilitytransformation/" id="ftr-sustainabilitytransformation">PLOS Sustainability and Transformation</a></li>
    <li><a href="/water/" id="ftr-water">PLOS Water</a></li>
  </ul>
    </div>
    <div class="block xx-small">	


<ul class="nav nav-tertiary">
  <li>
    <a href="https://plos.org" id="ftr-home">Home</a>
  </li>
  <li>
    <a href="https://blogs.plos.org" id="ftr-blog">Blogs</a>
  </li>
  <li>
    <a href="https://collections.plos.org/" id="ftr-collections">Collections</a>
  </li>
  <li>
    <a href="mailto:webmaster@plos.org" id="ftr-feedback">Give feedback</a>
  </li>
  <li>
    <a href="/plosone/lockss-manifest" id="ftr-lockss">LOCKSS</a>
  </li>
</ul>
    </div>
    <div class="block xx-small">

<ul class="nav nav-primary">
  <li><a href="https://plos.org/privacy-policy" id="ftr-privacy">Privacy Policy</a></li>
  <li><a href="https://plos.org/terms-of-use" id="ftr-terms">Terms of Use</a></li>
  <li><a href="https://plos.org/advertise/" id="ftr-advertise">Advertise</a></li>
  <li><a href="https://plos.org/media-inquiries" id="ftr-media">Media Inquiries</a></li>
  <li><a href="https://plos.org/contact" id="ftr-contact">Contact</a></li>
</ul>
    </div>
  </div>
  <div class="row">
    <p>

<img src="/resource/img/logo-plos-footer.png" alt="PLOS" class="logo-footer"/>


<span class="footer-non-profit-statement">PLOS is a nonprofit 501(c)(3) corporation, #C2354500, based in San Francisco, California, US</span>    </p>
    <div class="block">

&nbsp;
<!--
  Webapp build:  3.7.29-SNAPSHOT at 20220301175124 by root, commit: addc5e2
  Service build: 2.6.0-SNAPSHOT at 20220222171921 by root, commit: 20f030d
  -->
    </div>
  </div>
 
<script src="/resource/js/global.js" type="text/javascript"></script>
</footer>




<script type="text/javascript">
  var ArticleData = {
    doi: '10.1371/journal.pone.0096343',
    title: '<article-title xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">Sparstolonin B, a Novel Plant Derived Compound, Arrests Cell Cycle and Induces Apoptosis in N-Myc Amplified and N-Myc Nonamplified Neuroblastoma Cells<\/article-title>',
    date: 'May 01, 2014'
  };
</script>
<script src="/resource/js/components/show_onscroll.js" type="text/javascript"></script>
<script src="/resource/js/vendor/spin.js" type="text/javascript"></script>
<script src="/resource/js/pages/article.js" type="text/javascript"></script>
<script src="/resource/js/pages/article_sidebar.js" type="text/javascript"></script>
<script src="/resource/js/pages/article_references.js" type="text/javascript"></script>
<script src="/resource/js/vendor/foundation/foundation.dropdown.js" type="text/javascript"></script>
  <script src="/resource/js/components/table_open.js" type="text/javascript"></script>

        <script src="/resource/js/components/figshare.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/jquery.panzoom.min.js" type="text/javascript"></script>
  <script src="/resource/js/vendor/jquery.mousewheel.js" type="text/javascript"></script>

  <script src="/resource/js/components/lightbox.js" type="text/javascript"></script>

  <script src="/resource/js/pages/article_body.js" type="text/javascript"></script>


<!-- This file should be loaded before the renderJs, to avoid conflicts with the FigShare, that implements the MathJax also. -->

<!--  mathjax configuration options  -->
<!-- more can be found at http://docs.mathjax.org/en/latest/ -->
<script type="text/x-mathjax-config">
MathJax.Hub.Config({
  "HTML-CSS": {
    scale: 100,
    availableFonts: ["STIX","TeX"],
    preferredFont: "STIX",
    webFont: "STIX-Web",
    linebreaks: { automatic: false }
  },
  jax: ["input/MathML", "output/HTML-CSS"]
});
</script>

<script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=MML_HTMLorMML"></script>

<div class="reveal-modal-bg"></div>
</body>
</html>
